Columbia Sportswear (COLM) 10-Q 5 Nov 20 2020 Q3 Quarterly report Financial data

Cover Page

Cover Page - shares	9 Months Ended
	Sep. 30, 2020	Oct. 23, 2020
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Sep. 30, 2020
Document Transition Report	false
Entity File Number	000-23939
Entity Registrant Name	COLUMBIA SPORTSWEAR COMPANY
Entity Incorporation, State or Country Code	OR
Entity Tax Identification Number	93-0498284
Entity Address, Address Line One	14375 Northwest Science Park Drive
Entity Address, City or Town	Portland
Entity Address, State or Province	OR
Entity Address, Postal Zip Code	97229
City Area Code	503
Local Phone Number	985-4000
Title of 12(b) Security	Common stock
Trading Symbol	COLM
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		66,211,981
Amendment Flag	false
Document Fiscal Year Focus	2020
Document Fiscal Period Focus	Q3
Entity Central Index Key	0001050797
Current Fiscal Year End Date	--12-31

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Sep. 30, 2020	Dec. 31, 2019	Sep. 30, 2019
Operating Lease, Liability, Noncurrent	$ 337,108	$ 371,507	$ 366,515
Current Assets:
Cash and cash equivalents	313,429	686,009	239,311
Short-term investments	1,095	1,668	1,477
Accounts receivable, net of allowance of $6,887, $9,043 and $8,666, respectively	479,376	488,233	646,414
Inventories	771,724	605,968	717,396
Prepaid expenses and other current assets	82,175	93,868	94,253
Total current assets	1,647,799	1,875,746	1,698,851
Property, plant and equipment, at cost, net of accumulated depreciation of $472,447, $455,811 and $435,625, respectively	322,167	346,651	349,302
Operating Lease, Right-of-Use Asset	351,277	394,501	389,558
Intangible assets, net (Note 5)	121,471	123,595	124,340
Goodwill	68,594	68,594	68,594
Deferred Income Tax Assets, Net	77,055	78,849	80,193
Other non-current assets	63,951	43,655	40,242
Total assets	2,652,314	2,931,591	2,751,080
Current Liabilities:
Accounts payable	164,332	255,372	201,806
Accrued liabilities (Note 6)	257,040	295,723	279,932
Operating Lease, Liability, Current	73,409	64,019	62,756
Income taxes payable	4,813	15,801	13,653
Total current liabilities	499,594	630,915	558,147
Operating Lease, Liability, Noncurrent	337,108	371,507	366,515
Income taxes payable, noncurrent	49,195	48,427	48,619
Deferred Income Tax Liabilities, Net	7,149	6,361	7,711
Other Liabilities, Noncurrent	36,452	24,934	22,982
Total liabilities	929,498	1,082,144	1,003,974
Commitments and Contingencies
Equity:
Preferred stock; 10,000 shares authorized; none issued and outstanding	0	0	0
Common stock (no par value); 250,000 shares authorized; 69,988, 69,995, and 69,686 issued and outstanding, respectively (Note 9)	13,142	4,937	0
Retained earnings	1,716,044	1,848,935	1,754,379
Accumulated other comprehensive loss (Note 8)	(6,370)	(4,425)	(7,273)
Total shareholders' equity	1,722,816	1,849,447	1,747,106
Total liabilities and equity	$ 2,652,314	$ 2,931,591	$ 2,751,080

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Thousands	Sep. 30, 2020	Dec. 31, 2019	Sep. 30, 2019
Statement of Financial Position [Abstract]
Allowance for doubtful accounts	$ 29,760	$ 8,925	$ 9,672
Accumulated depreciation for property, plant and equipment	$ 550,097	$ 523,092	$ 515,300
Preferred stock, shares authorized (in shares)	10,000,000	10,000,000	10,000,000
Preferred stock, shares issued (in shares)	0	0	0
Preferred stock, shares outstanding (in shares)	0	0	0
Common stock, no par value (in dollars per share)	$ 0	$ 0	$ 0
Common stock, shares authorized (in shares)	250,000,000	250,000,000	250,000,000
Common Stock, Shares, Issued	66,210,000	67,561,000	67,562,000
Common Stock, Shares, Outstanding	66,210,000	67,561,000	67,562,000

Condensed Consolidated Statemen

Condensed Consolidated Statements Of Operations - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Net sales	$ 701,092	$ 906,793	$ 1,585,931	$ 2,087,611
Cost of sales	358,184	460,098	825,079	1,050,596
Gross profit	342,908	446,695	760,852	1,037,015
Selling, general and administrative expenses	261,192	299,249	755,664	791,767
Net licensing income	3,927	4,569
Income from operations	85,643	152,015	13,356	256,338
Interest income, net	(280)	1,399	728	7,370
Other non-operating expense	(465)	(563)	2,208	915
Income (Loss) Attributable to Parent, before Tax, Total	84,898	152,851	16,292	264,623
Income tax expense	(22,147)	(33,593)	(4,035)	(48,159)
Net income attributable to Columbia Sportswear Company	$ 62,751	$ 119,258	$ 12,257	$ 216,464
Earnings per share (Note 9):
Basic (in dollars per share)	$ 0.95	$ 1.76	$ 0.18	$ 3.19
Diluted (in dollars per share)	$ 0.94	$ 1.75	$ 0.18	$ 3.15
Weighted average shares outstanding (Note 9):
Basic (in shares)	66,179	67,593	66,427	67,935
Diluted (in shares)	66,537	68,180	66,807	68,620
License [Member]
Net licensing income			$ 8,168	$ 11,090

Condensed Consolidated Statem_2

Condensed Consolidated Statements Of Comprehensive Income - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Net Income (Loss) Attributable to Parent	$ 62,751	$ 119,258	$ 12,257	$ 216,464
Other comprehensive income:
Unrealized holding gains on available-for-sale securities, net			0	56
Unrealized gains (losses) on derivative transactions (net of tax effects of $3,995, $(801), $1,371 and $(369), respectively)	(11,685)	2,414	(5,022)	1,866
Foreign currency translation adjustments (net of tax effects of $(290), $1,560, $(253) and $2,447, respectively)	11,175	(8,389)	3,077	(5,033)
Other comprehensive income	(510)	(5,975)	(1,945)	(3,111)
Comprehensive income attributable to Columbia Sportswear Company	62,241	113,283
Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, Tax	3,995	(801)	1,371	(369)
Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax	(290)	1,560	(253)	2,447
Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest			$ 10,312	213,353
AOCI Attributable to Parent [Member]
Other comprehensive income:
Unrealized holding gains on available-for-sale securities, net	0	0
Unrealized gains (losses) on derivative transactions (net of tax effects of $3,995, $(801), $1,371 and $(369), respectively)	(11,685)
Foreign currency translation adjustments (net of tax effects of $(290), $1,560, $(253) and $2,447, respectively)	$ 11,175	$ (8,389)		$ (5,033)

Condensed Consolidated Statem_3

Condensed Consolidated Statements Of Comprehensive Income (Parenthetical) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Statement of Comprehensive Income [Abstract]
Unrealized losses on derivative transactions tax effects	$ (3,995)	$ 801	$ (1,371)	$ 369
Foreign currency translation adjustments tax effects	$ 290	$ (1,560)	$ 253	$ (2,447)

Condensed Consolidated Statem_4

Condensed Consolidated Statements Of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019
Payments to Noncontrolling Interests	$ 0	$ (17,880)
Cash flows from operating activities:
Net income	12,257	216,464
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	102,283	88,775
Accounts Receivable, Credit Loss Expense (Reversal)	24,684	(242)
Loss on disposal of property, plant, and equipment	8,981	4,866
Deferred income taxes	4,306	(3,157)
Stock-based compensation	12,802	13,159
Changes in operating assets and liabilities:
Accounts receivable	(17,130)	(199,174)
Inventories	(160,090)	(198,999)
Prepaid expenses and other current assets	9,098	(12,596)
Other assets	(20,786)	(3,981)
Accounts payable	(89,790)	(65,191)
Accrued liabilities	(41,182)	6,497
Income taxes payable	(10,011)	(11,286)
Increase (Decrease) In Operating Lease Assets And Liabilities	(41,459)	(39,010)
Other liabilities	8,077	5,716
Net cash provided by operating activities	(197,960)	(198,159)
Cash flows from investing activities:
Purchases of short-term investments	(35,044)	(181,257)
Proceeds from Sale, Maturity and Collection of Short-term Investments	36,630	445,501
Capital expenditures	(25,164)	(104,527)
Net cash used in investing activities	(23,578)	159,717
Cash flows from financing activities:
Proceeds from credit facilities	387,992	74,053
Repayments on credit facilities	(388,465)	(74,053)
Proceeds from issuance of common stock under employee stock plans	4,793	17,687
Tax payments related to restricted stock unit issuances	(4,454)	(5,739)
Payments for Repurchase of Common Stock	(132,889)	(116,239)
Payments to Noncontrolling Interests	0	17,880
Cash dividends paid	(17,195)	(48,917)
Net cash used in financing activities	(152,314)	(171,088)
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	1,272	(2,954)
Net increase (decrease) in cash and cash equivalents	(372,580)	(212,484)
Cash, cash equivalents and restricted cash, beginning of period	686,009	451,795
Cash, cash equivalents and restricted cash, end of period	313,429	239,311
Supplemental disclosures of cash flow information:
Cash paid during the period for income taxes	18,385	73,413
Supplemental disclosures of non-cash investing activities:
Capital expenditures incurred but not yet paid	4,774	11,638
Payments of Debt Issuance Costs	$ 2,096	$ 0

Condensed Consolidated Statem_5

Condensed Consolidated Statements of Equity Condensed Consolidated Statements of Equity - USD ($) shares in Thousands, $ in Thousands	Total	Common Stock [Member]	Retained Earnings [Member]	AOCI Attributable to Parent [Member]	Non-controlling Interest [Member]
Common Stock, Shares, Outstanding		68,246
Stockholders' Equity Attributable to Parent		$ 0	$ 1,677,920	$ (4,063)
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest	$ 1,690,313
Stockholders' Equity Attributable to Noncontrolling Interest					$ 16,456
Net income	216,464		216,464
Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests	16,555			99	16,456
Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Net of Tax	1,866
Unrealized holding gains on available-for-sale securities, net	56
Other Comprehensive Income (Loss), Securities, Available-for-sale, Adjustment, after Tax				56
Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, Net of Tax	1,866			1,866	0
Foreign currency translation adjustments (net of tax effects of $(290), $1,560, $(253) and $2,447, respectively)	(5,033)			(5,033)	0
Dividends, Cash	(48,917)		(48,917)
Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture		507
Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture	11,948	$ 11,948
APIC, Share-based Payment Arrangement, Increase for Cost Recognition	13,159	$ 13,159
Stock Repurchased During Period, Shares		(1,191)
Stock Repurchased During Period, Value	(116,195)	$ (25,107)	(91,088)
Common Stock, Shares, Outstanding		67,586
Stockholders' Equity Attributable to Parent		$ 100	1,656,392	(1,298)
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest	1,655,194
Net income	119,258		119,258
Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Net of Tax	2,414
Unrealized holding gains on available-for-sale securities, net				0
Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, Net of Tax	2,414			2,414
Foreign currency translation adjustments (net of tax effects of $(290), $1,560, $(253) and $2,447, respectively)	(8,389)			(8,389)
Dividends, Cash	(16,231)		(16,231)
Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture		135
Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture	6,251	$ 6,251
APIC, Share-based Payment Arrangement, Increase for Cost Recognition	4,378	$ 4,378
Stock Repurchased During Period, Shares		(159)
Stock Repurchased During Period, Value	$ (15,769)	$ (10,729)	(5,040)
Common Stock, Shares, Outstanding	67,562	67,562
Stockholders' Equity Attributable to Parent	$ 1,747,106	$ 0	1,754,379	(7,273)
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest	$ 1,747,106
Stockholders' Equity Attributable to Noncontrolling Interest					$ 0
Common Stock, Shares, Outstanding	67,561	67,561
Stockholders' Equity Attributable to Parent	$ 1,849,447	$ 4,937	1,848,935	(4,425)
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest	1,849,447
Net income	12,257		12,257
Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Net of Tax	(5,022)
Unrealized holding gains on available-for-sale securities, net	0
Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, Net of Tax	(5,022)
Foreign currency translation adjustments (net of tax effects of $(290), $1,560, $(253) and $2,447, respectively)	3,077
Dividends, Cash	(17,195)		(17,195)
Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture		206
Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture	339	$ 339
APIC, Share-based Payment Arrangement, Increase for Cost Recognition	12,802	$ 12,802
Stock Repurchased During Period, Shares		(1,557)
Stock Repurchased During Period, Value	(132,889)	$ (4,936)	(127,953)
Common Stock, Shares, Outstanding		66,148
Stockholders' Equity Attributable to Parent		$ 5,396	1,653,293	(5,860)
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest	1,652,829
Net income	62,751		62,751
Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Net of Tax	(11,685)			(11,685)
Unrealized holding gains on available-for-sale securities, net				0
Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, Net of Tax	(11,685)
Foreign currency translation adjustments (net of tax effects of $(290), $1,560, $(253) and $2,447, respectively)	11,175			11,175
Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture		62
Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture	2,656	$ 2,656
APIC, Share-based Payment Arrangement, Increase for Cost Recognition	5,090	$ 5,090
Stock Repurchased During Period, Value	$ (132,900)
Common Stock, Shares, Outstanding	66,210	66,210
Stockholders' Equity Attributable to Parent	$ 1,722,816	$ 13,142	1,716,044	(6,370)
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest	$ 1,722,816	$ 13,142	$ 1,716,044	$ (6,370)

Condensed Consolidated Statem_6

Condensed Consolidated Statements of Equity Parenthetical - $ / shares	3 Months Ended	9 Months Ended
	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Statement of Stockholders' Equity [Abstract]
Common Stock, Dividends, Per Share, Cash Paid	$ 0.24	$ 0.26	$ 0.72

Basis Of Presentation And Organ

Basis Of Presentation And Organization	9 Months Ended
	Sep. 30, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Basis of Presentation and Organization	The accompanying unaudited condensed consolidated financial statements have been prepared by the management of Columbia Sportswear Company (together with its wholly owned subsidiaries, the "Company") and, in the opinion of management, include all normal recurring material adjustments necessary to present fairly the Company's financial position as of September 30, 2020, December 31, 2019 and September 30, 2019, and the results of operations for the three and nine months ended September 30, 2020 and 2019, and cash flows for the nine months ended September 30, 2020 and 2019. The December 31, 2019 financial information was derived from the Company's audited consolidated financial statements included in the Company's Annual Report on Form 10-K for the year ended December 31, 2019. A significant part of the Company's business is of a seasonal nature; therefore, results of operations for the three and nine months ended September 30, 2020 are not necessarily indicative of results to be expected for other quarterly periods or for the full year. Certain information and disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America ("GAAP") have been condensed or omitted pursuant to the rules and regulations of the Securities and Exchange Commission. The Company, however, believes that the disclosures contained in this report comply with the requirements of Section 13(a) of the Securities Exchange Act of 1934, as amended, for a Quarterly Report on Form 10-Q and are adequate to make the information presented not misleading. These unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto included in the Company's Annual Report on Form 10-K for the year ended December 31, 2019. Principles of Consolidation The condensed consolidated financial statements include the accounts of Columbia Sportswear Company and its wholly owned subsidiaries. All significant intercompany balances and transactions have been eliminated in consolidation. Estimates and Assumptions The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results may differ from these estimates and assumptions. Some of the more significant estimates relate to revenue recognition, allowance for uncollectible accounts receivable, excess, close-out and slow moving inventory, product warranty, impairment of long-lived assets, intangible assets and goodwill, income taxes, and stock-based compensation. COVID-19 A novel strain of coronavirus ("COVID-19") was first identified in China in December 2019 and a global pandemic of respiratory disease caused by COVID-19 was declared by the World Health Organization in March 2020. The current environment of uncertainty significantly affected the September 30, 2020 estimates for allowance for uncollectible accounts receivable and excess, close-out and slow-moving inventory. These estimates involve assumptions about future events. The allowance for uncollectible accounts receivable includes assumptions about the future financial condition of the Company's customers and their ability to make required payments. The provision for excess, close-out and slow moving inventory includes assumptions about future demand for the Company’s products and the Company's ability to sell them at a profit. As a result of lower consumer demand related to the COVID-19 pandemic, the Company tested certain retail locations and their respective lease right-of-use assets for impairment. For the three and nine months ended September 30, 2020, impairment charges for certain underperforming retail stores were $0.1 million and $6.7 million, respectively. These charges were recognized in Selling, general and administrative expenses (" SG&A expense "). Additionally, as a result of the COVID-19 pandemic and a significant decline in projected net sales, the prAna brand's trademark and goodwill were tested for impairment as of March 31, 2020. While no impairment was indicated during the first quarter 2020 tests, the degree by which the fair value of the prAna reporting unit and trademark exceeded their respective carrying values declined from the Company's 2019 impairment test. After performing both qualitative and quantitative analysis, including review of future long-term revenue and cash flow assumptions, the Company concluded a triggering event requiring measurement of the prAna brand's trademark and goodwill for impairment during the quarter ended September 30, 2020 did not occur. As of September 30, 2020, the Company received or negotiated lease concessions related to the effects of the COVID-19 pandemic on a portion of its stores. In April 2020, the Financial Accounting Standards Board (“FASB”) issued a Staff Q&A, Topic 842 and 840: Accounting for Lease Concessions Related to the Effects of the COVID-19 Pandemic. The FASB staff indicated that it would be acceptable for entities to make an election to account for lease concessions related to the effects of the COVID-19 pandemic consistent with how they would be accounted for as though enforceable rights and obligations for those concessions existed in the original contract. The Company elected to account for lease concessions related to the effects of the COVID-19 pandemic in accordance with the Staff Q&A. For concessions that provide a deferral of payments with no substantive changes to the consideration in the original contract, the Company continues to recognize expense during the deferral period. For concessions in the form of lease abatements, the reduced lease payments are accounted for as reductions to variable lease expense. In the periods presented, lease concessions reducing variable lease expense were not material. In response to the COVID-19 pandemic, the Coronavirus Aid, Relief, and Economic Security Act (the “CARES Act”) was signed into law in the United States on March 27, 2020. The CARES Act provides payroll tax credits for employee retention, deferral of payroll tax payments and several income tax provision modifications. Additionally, there are other subsidies and incentives provided by foreign governments in the countries where the Company conducts business. For the three and nine months ended September 30, 2020, $2.8 million and $7.1 million, respectively, of government subsidies and incentives reduced SG&A expense . Recently Adopted Accounting Pronouncements Effective January 1, 2020, the Company adopted Accounting Standards Update ("ASU") No. 2018-15, Intangibles - Goodwill and Other - Internal-Use Software (Subtopic 350-40) issued by the FASB in August 2018, which clarifies certain aspects of accounting for implementation costs incurred in a cloud computing arrangement ("CCA") that is a service contract. Under the ASU, an entity would expense costs incurred in the preliminary-project and post-implementation-operation stages. The entity would also capitalize certain costs incurred during the application-development stage, as well as certain costs related to enhancements. The ASU does not change the accounting for the service component of a CCA. The Company adopted the standard using the prospective method and anticipates an increase in cloud-specific implementation assets as specific cloud initiatives are executed by the Company. These assets will generally be included in Other non-current assets in the Condensed Consolidated Balance Sheets and will amortize over their assessed useful lives or the term of the underlying cloud computing hosting contract, whichever is shorter. Upon the adoption of the standard, there was no immediate impact to the Company's financial position, results of operations or cash flows. Effective January 1, 2020, the Company adopted ASU No. 2017-04, Intangibles - Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment issued by the FASB in January 2017, which simplifies the accounting for goodwill impairments by eliminating step two from the goodwill impairment test. Under this guidance, if the carrying amount of a reporting unit exceeds its estimated fair value, an impairment charge shall be recognized in an amount equal to that excess, limited to the total amount of goodwill allocated to that reporting unit. The impact of the new standard will depend on the specific facts and circumstances of future individual goodwill impairments, if any. Effective January 1, 2020, the Company adopted ASU No. 2016-13, Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments issued by the FASB in June 2016, as well as the clarifying amendments subsequently issued. The pronouncement changes the impairment model for most financial assets and will require the use of an "expected loss" model for instruments measured at amortized cost. Under this model, entities will be required to estimate the lifetime expected credit loss on such instruments and record an allowance to offset the amortized cost basis of the financial asset, resulting in a net presentation of the amount expected to be collected on the financial asset. Upon adoption of the standard, there was no immediate impact to the Company's financial position, results of operations or cash flows. On an ongoing basis, the Company will contemplate forward-looking economic conditions in recording lifetime expected credit losses for the Company’s financial assets measured at cost, such as the Company’s trade receivables and certain short-term investments. Summary of Significant Accounting Policies Except as disclosed below, there have been no significant changes to the Company's significant accounting policies as described in Note 2 in the Company's Annual Report on Form 10-K for the year ended December 31, 2019. The following significant accounting policies have been updated since the Company’s 2019 Annual Report on Form 10-K as a result of the adoption of ASU No. 2016-13 and ASU No. 2018-15, respectively: Accounts Receivable Accounts receivable have been reduced by an allowance for doubtful accounts. The Company maintains the allowance for estimated losses resulting from the inability of the Company's customers to make required payments. The allowance represents the current estimate of lifetime expected credit losses over the remaining duration of existing accounts receivable considering current market conditions and supportable forecasts when appropriate. The estimate is a result of the Company’s ongoing evaluation of collectability, customer creditworthiness, historical levels of credit losses, and future expectations. Write-off activity and recoveries for the periods presented were not material. Cloud Computing Arrangements The Company’s CCAs primarily relate to various enterprise resource planning systems, as well as other supporting systems. These assets are generally included in Other non-current assets in the Condensed Consolidated Balance Sheets and amortize on a straight-line basis over their assessed useful lives or the term of the underlying cloud computing hosting contract, whichever is shorter. As of September 30, 2020, assets were in-service with useful lives ranging from ten months to five years. As of September 30, 2020, CCA assets consisted of capitalized implementation costs of $24.1 million and associated accumulated amortization of $0.7 million. Changes in these assets are recorded in Other assets within operating activities in the Condensed Consolidated Statements of Cash Flows. In December 2019, the FASB issued ASU No. 2019-12 ,

Revenues

Revenues	9 Months Ended
	Sep. 30, 2020
Revenue from Contract with Customer [Abstract]
Revenues	Disaggregated Revenue As disclosed below in Note 12, the Company has four geographic reportable segments: United States ("U.S."), Latin America and Asia Pacific ("LAAP"), Europe, Middle East and Africa ("EMEA"), and Canada. The following tables disaggregate the Company's operating segment Net sales by product category and sales channel, which the Company believes provide a meaningful depiction of how the nature, timing, and uncertainty of Net sales are affected by economic factors: Three Months Ended September 30, 2020 (in thousands) U.S. LAAP EMEA Canada Total Product category net sales Apparel, Accessories and Equipment $ 332,713 $ 70,026 $ 66,160 $ 41,221 $ 510,120 Footwear 112,907 20,925 32,999 24,141 190,972 Total $ 445,620 $ 90,951 $ 99,159 $ 65,362 $ 701,092 Sales channel net sales Wholesale $ 282,850 $ 50,723 $ 85,074 $ 52,820 $ 471,467 Direct-to-consumer 162,770 40,228 14,085 12,542 229,625 Total $ 445,620 $ 90,951 $ 99,159 $ 65,362 $ 701,092 Three Months Ended September 30, 2019 (in thousands) U.S. LAAP EMEA Canada Total Product category net sales Apparel, Accessories and Equipment $ 459,633 $ 93,486 $ 66,058 $ 65,532 $ 684,709 Footwear 121,630 29,760 38,345 32,349 222,084 Total $ 581,263 $ 123,246 $ 104,403 $ 97,881 $ 906,793 Sales channel net sales Wholesale $ 396,275 $ 77,934 $ 91,329 $ 86,993 $ 652,531 Direct-to-consumer 184,988 45,312 13,074 10,888 254,262 Total $ 581,263 $ 123,246 $ 104,403 $ 97,881 $ 906,793 Nine months ended September 30, 2020 (in thousands) U.S. LAAP EMEA Canada Total Product category net sales Apparel, Accessories and Equipment $ 793,846 $ 193,815 $ 145,100 $ 73,445 $ 1,206,206 Footwear 210,887 67,097 68,198 33,543 379,725 Total $ 1,004,733 $ 260,912 $ 213,298 $ 106,988 $ 1,585,931 Sales channel net sales Wholesale $ 559,052 $ 139,316 $ 180,416 $ 78,546 $ 957,330 Direct-to-consumer 445,681 121,596 32,882 28,442 628,601 Total $ 1,004,733 $ 260,912 $ 213,298 $ 106,988 $ 1,585,931 Nine Months Ended September 30, 2019 (in thousands) U.S. LAAP EMEA Canada Total Product category net sales Apparel, Accessories and Equipment $ 1,081,942 $ 267,919 $ 183,168 $ 109,909 $ 1,642,938 Footwear 227,072 89,800 84,110 43,691 444,673 Total $ 1,309,014 $ 357,719 $ 267,278 $ 153,600 $ 2,087,611 Sales channel net sales Wholesale $ 756,558 $ 200,083 $ 231,219 $ 124,119 $ 1,311,979 Direct-to-consumer 552,456 157,636 36,059 29,481 775,632 Total $ 1,309,014 $ 357,719 $ 267,278 $ 153,600 $ 2,087,611 Performance Obligations For the three and nine months ended September 30, 2020 and 2019, Net sales recognized from performance obligations related to prior periods were not material. Net sales expected to be recognized in any future period related to remaining performance obligations is not material. Contract Balances As of September 30, 2020, December 31, 2019 and September 30, 2019, contract liabilities included in Accrued liabilities on the Condensed Consolidated Balance Sheets, which consisted of obligations associated with the Company's gift card and customer loyalty programs, were not material.

Intangible Assets, Net

Intangible Assets, Net	9 Months Ended
	Sep. 30, 2020
Goodwill and Intangible Assets Disclosure [Abstract]
Intangible Assets, Net	NOTE 3—INTANGIBLE ASSETS, NET Intangible assets, net consisted of the following: (in thousands) September 30, December 31, September 30, Intangible assets subject to amortization: Patents and purchased technology $ 14,198 $ 14,198 $ 14,198 Customer relationships 23,000 23,000 23,000 Gross carrying amount 37,198 37,198 37,198 Accumulated amortization: Patents and purchased technology (14,198) (13,311) (12,979) Customer relationships (16,950) (15,713) (15,300) Total accumulated amortization (31,148) (29,024) (28,279) Net carrying amount 6,050 8,174 8,919 Intangible assets not subject to amortization 115,421 115,421 115,421 Intangible assets, net $ 121,471 $ 123,595 $ 124,340 Amortization expense for intangible assets subject to amortization was $0.6 million and $0.7 million for the three months ended September 30, 2020 and 2019, respectively, and was $2.1 million and $2.2 million for the nine months ended September 30, 2020 and 2019, respectively. Annual amortization expense is estimated to be as follows for the years 2020 through 2024: (in thousands) 2020 $ 2,537 2021 1,650 2022 1,650 2023 1,650 2024 688

Short Term Borrowings and Credi

Short Term Borrowings and Credit Lines	9 Months Ended
	Sep. 30, 2020
Debt Disclosure [Abstract]
Short-Term Borrowings and Credit Lines	NOTE 4—SHORT-TERM BORROWINGS AND CREDIT LINES At the beginning of 2020, the Company had an unsecured, committed revolving line of credit agreement, maturing on August 1, 2023 with monthly variable commitments available for funding that averaged $50.0 million over the course of a calendar year. In March 2020, the Company entered into a first amendment to its unsecured, committed revolving line of credit agreement to remove the seasonality within the commitment levels and provide $125.0 million in committed borrowing availability through December 31, 2020. In April 2020, the Company entered into a second amended and restated credit agreement (the “restated credit agreement”) which amended and restated the committed revolving line of credit agreement. The restated credit agreement provides for (i) a secured, committed revolving line of credit, maturing on August 1, 2023 with a commitment available for funding of $125.0 million (the "Revolving A Loan"), (ii) a secured, committed revolving line of credit, maturing April 13, 2021, with a commitment available for funding of $400.0 million (the "Revolving B Loan", together with the Revolving A Loan, the "Revolving Loans"), and (iii) an uncommitted $100.0 million incremental facility, which may be added to the Revolving B Loan if it is executed on, upon request by the Company to the administrative agent. Advances under the Revolving Loans can be either LIBOR loans or base rate loans. LIBOR loans bear interest on the outstanding principal amount thereof for each interest period at a rate per annum equal to LIBOR (subject to a LIBOR floor) plus a margin ranging from 2.00% to 2.75% (the "LIBOR Margin"). Base rate loans bear interest on the outstanding principal amount thereof at a rate per annum equal to the LIBOR Margin plus the greater of (i) daily reset one month LIBOR or (ii) in the case of Revolving A Loans, the LIBOR floor; provided that if the lenders are unable to price loans based on LIBOR, base rate loans will bear interest at an interest rate per annum equal to a margin ranging from 1.00% to 1.75% plus the higher of (A) the rate of interest most recently announced by the administrative agent as its prime rate or (B) the federal funds rate plus 1.50%. In addition, the restated credit agreement requires the Company to comply with certain financial covenants. If the Company is in default, it is required to comply with certain restrictions on dividend payments and stock repurchases. In connection with the restated agreement, the Company entered into a collateral agreement under which the obligations of the Company were secured by all assets of the Company and Columbia Brands USA, LLC, except for intellectual property, real property, equity interests in foreign subsidiaries and certain other exclusions. Effective July 10, 2020, the Company entered into a first amendment (the "first amendment") to its restated credit agreement. The first amendment provides for suspensions of and adjustments to the financial covenants beginning on July 1, 2020 through December 31, 2020 (the "covenant suspension period") as follows: (i) the funded debt ratio no longer needs to be maintained during the covenant suspension period, (ii) the interest coverage ratio no longer needs to be maintained during the covenant suspension period, and (iii) the Company must maintain liquidity (inclusive of unrestricted and unencumbered cash-on-hand of the Company and its subsidiaries and, with certain limitations, availability under the revolving credit facilities provided for in the restated credit agreement) of not less than $200.0 million as of each calendar month end during the covenant suspension period. In addition, the minimum LIBOR floors were revised to be 0.50% in the case of both Revolving A and Revolving B loans. The first amendment also provides for a letter of credit facility and contains modifications to certain other negative covenants, including a change to the negative indebtedness covenant to allow for up to $350 million in additional unsecured indebtedness. In connection with the first amendment, the Company amended and restated the collateral agreement, originally dated April 15, 2020 to provide for a pledge by the Company and Columbia Brands USA, LLC of 65% of their equity interests in foreign subsidiaries. At September 30, 2020, the Company was in compliance with all associated covenants, and there was no balance outstanding under these lines and facility. The Company’s Canadian subsidiary has available an unsecured and uncommitted line of credit, which is payable on demand, guaranteed by the Company, and provides for borrowings up to a maximum of CAD$30.0 million (approximately US$22.4 million) at September 30, 2020. The revolving line accrues interest at the Canadian Prime rate for CAD overdraft borrowings or Bankers' Acceptance rate plus 150 basis points for Bankers' Acceptance loans. As of September 30, 2020, there was no balance outstanding under this line of credit. At the beginning of 2020, the Company's European subsidiary had two separate unsecured and uncommitted lines of credit, guaranteed by the Company, and provides for borrowings up to a maximum of €25.8 million and €5.0 million. In June 2020, the Company's European subsidiary entered into an agreement which replaced the €5.0 million line with a €4.4 million secured, committed line of credit, and a €0.6 million unsecured and uncommitted line of credit. The combined available borrowings of the three lines was approximately US$36.2 million at September 30, 2020. Borrowings under the €25.8 million line accrue interest at a base rate of 185 basis points plus 200 basis points. Borrowings under the €4.4 million and €0.6 million lines each accrue interest at 75 basis points. As of September 30, 2020, there was no balance outstanding under these facilities. At the beginning of the third quarter of 2020, the Company’s Japanese subsidiary had available two separate unsecured and uncommitted overdraft facilities guaranteed by the Company providing for borrowing up to a maximum of US$7.0 million and ¥300.0 million. During the third quarter of 2020, the overdraft facility with a maximum borrowing of ¥300.0 million was modified to increase the maximum borrowing to ¥1.5 billion. The combined maximum borrowings of the two lines were approximately US$21.2 million at September 30, 2020. Borrowings under the ¥1.5 billion overdraft facility accrue interest at the Tokyo Interbank Offered Rate plus 0.50 basis points and borrowings under the US$7.0 million overdraft facility accrue interest at 200 basis points. As of September 30, 2020, there was no balance outstanding under these facilities. The Company’s Korea subsidiary has available an unsecured and uncommitted overdraft facility guaranteed by the Company providing for borrowing up to a maximum of US$20.0 million at September 30, 2020. Borrowings under the overdraft facility accrue interest at the Korea three month CD rate plus 200 basis points. As of September 30, 2020, there was no balance outstanding under this overdraft facility. At the beginning of the third quarter of 2020, the Company’s Chinese subsidiary had available an unsecured and uncommitted overdraft and clean advance facility guaranteed by the Company providing for borrowings of advances or overdrafts up to a maximum of US$20.0 million at September 30, 2020. Borrowings under the facility accrue interest on advances of RMB at 4.15%, advances of USD based on LIBOR plus 2.0% per annum or overdrafts of RMB based on 110% of the PBOC rate. In September 2020, the Company's Chinese subsidiary entered into an unsecured and uncommitted line of credit, guaranteed by the Company that provides for borrowings up to a maximum of RMB140.0 million. Borrowings under the facility accrue interest at the one year loan prime rate less 10 basis points. The combined available borrowings of the two lines were approximately US$40.5 million at September 30, 2020. As of September 30, 2020, there was no balance outstanding under these facilities.

Income Taxes

Income Taxes	9 Months Ended
	Sep. 30, 2020
Income Tax Disclosure [Abstract]
Income Taxes	For the three months ended September 30, 2020 and 2019, the Company's effective income tax rates were 26.1% and 22.0%, respectively. For the nine months ended September 30, 2020 and 2019, the effective income tax rates were 24.8% and 18.2%, respectively. The increase in the effective income tax rate for the three months ended September 30, 2020 compared to the three months ended September 30, 2019 was primarily driven by the change in mix of book income or loss among jurisdictions. The increase in the effective income tax rate for the nine months ended September 30, 2020 compared to the nine months ended September 30, 2019 was driven primarily by the change in mix of book income or loss among jurisdictions, and the recognition in 2019 of a one-time tax benefit related to the passage of a Swiss tax reform package. Income tax expense, deferred tax assets and related liabilities are based on estimates. In the three months ended March 31, 2020, a $1.5 million valuation allowance adjustment was recorded related to the expected portion of tax benefits that would not be realized in certain foreign jurisdictions based on available evidence. The likelihood of realizing the benefits of the deferred tax assets was assessed as of

Product Warranty

Product Warranty	9 Months Ended
	Sep. 30, 2020
Product Warranties Disclosures [Abstract]
Product Warranty	Some of the Company's products carry life-time or limited warranty provisions for defects in quality and workmanship. A warranty reserve is established at the time of sale to cover estimated costs based on the Company's history of warranty repairs and replacements and is recorded in Cost of sales in the Condensed Consolidated Statements of Operations. The warranty reserve is included in Accrued liabilities in the Condensed Consolidated Balance Sheets. A reconciliation of product warranties is as follows: Three Months Ended September 30, Nine Months Ended September 30, (in thousands) 2020 2019 2020 2019 Balance at beginning of period $ 13,334 $ 13,186 $ 14,466 $ 13,186 Provision for warranty claims 525 645 1,430 3,140 Warranty claims (493) (440) (2,378) (2,899) Other 175 (180) 23 (216) Balance at end of period $ 13,541 $ 13,211 $ 13,541 $ 13,211

Commitments And Contingencies

Commitments And Contingencies	9 Months Ended
	Sep. 30, 2020
Commitments and Contingencies Disclosure [Abstract]
Commitments And Contingencies	The Company is a party to various legal claims, actions and complaints from time to time. Although the ultimate resolution of legal proceedings cannot be predicted with certainty, management believes that disposition of these matters will not have a material adverse effect on the Company's condensed consolidated financial statements.

Shareholders' Equity

Shareholders' Equity	9 Months Ended
	Sep. 30, 2020
Equity [Abstract]
Stockholders' Equity Note Disclosure [Text Block]	Since the inception of the Company's stock repurchase plan in 2004 through September 30, 2020, the Company's Board of Directors has authorized the purchase of $1.1 billion of the Company's common stock. As of September 30, 2020, the Company had repurchased 26.8 million shares under this program at an aggregate purchase price of $1,017.8 million. Shares repurchased generally settle subsequent to the trade date. Shares of the Company's common stock may be repurchased in the open market or through privately negotiated transactions, subject to market conditions. The repurchase program does not obligate the Company to acquire any specific number of shares or to acquire shares over any specified period of time. During the three months ended March 31, 2020, the Company repurchased an aggregate of $132.9 million of common stock under the stock repurchase plan authorized by the Company's Board of Directors and a pre-established written trading plan. In mid-March 2020, to reduce capital outflows and preserve capital, the Company suspended share repurchases.

Stock-Based Compensation

Stock-Based Compensation	9 Months Ended
	Sep. 30, 2020
Share-based Payment Arrangement, Noncash Expense [Abstract]
Stock-Based Compensation	NOTE 9—STOCK-BASED COMPENSATION At its Annual Meeting held on June 3, 2020, the Company’s shareholders approved the Company’s 2020 Stock Incentive Plan (the “2020 Plan”), and the 2020 Plan became effective on that date following such approval. The 2020 Plan replaced the Company’s 1997 Stock Incentive Plan (the "Prior Plan”) and no new awards will be granted under the Prior Plan. The terms and conditions of the awards granted under the Prior Plan will remain in effect with respect to awards granted under the Prior Plan. The Company has reserved 3 million shares of common stock for issuance under the 2020 Plan, plus up to an aggregate of 1.5 million shares of the Company’s common stock that were previously authorized and available for issuance under the Prior Plan. The 2020 Plan allows for grants of incentive stock options, non-statutory stock options, restricted stock awards, restricted stock units, and other stock-based or cash-based awards. Stock-based compensation expense Stock-based compensation expense consisted of the following: Three Months Ended September 30, Nine Months Ended September 30, (in thousands) 2020 2019 2020 2019 Stock options $ 1,775 $ 1,509 $ 5,234 $ 4,600 Restricted stock units 3,315 2,869 7,568 8,559 Total $ 5,090 $ 4,378 $ 12,802 $ 13,159 Stock Options During the nine months ended September 30, 2020, the Company granted a total of 660,071 stock options at a weighted average grant date fair value of $14.67. As of September 30, 2020, unrecognized costs related to outstanding stock options totaled $13.3 million, before any related tax benefit. As of September 30, 2020, unrecognized costs related to stock options are expected to be recognized over a weighted average period of 2.59 years. Restricted Stock Units During the nine months ended September 30, 2020, the Company granted 209,972 restricted stock units at an estimated average grant date fair value of $79.43. As of September 30, 2020, unrecognized costs related to outstanding restricted stock units totaled $21.5 million, before any related tax benefit. As of September 30, 2020, unrecognized costs related to restricted stock units are expected to be recognized over a weighted average period of 2.34 years.

Earnings Per Share

Earnings Per Share	9 Months Ended
	Sep. 30, 2020
Earnings Per Share [Abstract]
Earnings Per Share	NOTE 10—EARNINGS PER SHARE Earnings per share ("EPS") is presented on both a basic and diluted basis. Basic EPS is based on the weighted average number of common shares outstanding. Diluted EPS reflects the potential dilution that could occur if outstanding securities or other contracts to issue common stock were exercised or converted into common stock. A reconciliation of common shares used in the denominator for computing basic and diluted EPS is as follows: Three Months Ended September 30, Nine Months Ended September 30, (in thousands, except per share amounts) 2020 2019 2020 2019 Weighted average shares of common stock outstanding, used in computing basic earnings per share 66,179 67,593 66,427 67,935 Effect of dilutive stock options and restricted stock units 358 587 380 685 Weighted average shares of common stock outstanding, used in computing diluted earnings per share 66,537 68,180 66,807 68,620 Earnings per share of common stock: Basic $ 0.95 $ 1.76 $ 0.18 $ 3.19 Diluted $ 0.94 $ 1.75 $ 0.18 $ 3.15 Stock options, service-based restricted stock units, and performance-based restricted stock units representing 1,156,073 and 1,282,086 shares of common stock for the three and nine months ended September 30, 2020, respectively, were outstanding but were excluded from the computation of diluted EPS because their effect would have been anti-dilutive under the treasury stock method or because the shares were subject to performance conditions that had not been met.

Accumulated Other Comprehensive

Accumulated Other Comprehensive Income	9 Months Ended
	Sep. 30, 2020
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]
Accumulated Other Comprehensive Income	on the Company's Condensed Consolidated Balance Sheets is net of applicable taxes, and consists of unrealized holding gains and losses on available-for-sale securities, unrealized gains and losses on certain derivative transactions and foreign currency translation adjustments. The following table sets forth the changes in Accumulated other comprehensive loss for the three months ended September 30, 2020: (in thousands) Unrealized losses on available-for-sale securities Unrealized holding gains (losses) on derivative transactions Foreign currency translation adjustments Total Balance at June 30, 2020 $ (4) $ 16,145 $ (22,001) $ (5,860) Other comprehensive income (loss) before reclassifications — (6,398) 11,175 4,777 Amounts reclassified from accumulated other comprehensive loss (1) — (5,287) — (5,287) Net other comprehensive income (loss) during the period — (11,685) 11,175 (510) Balance at September 30, 2020 $ (4) $ 4,460 $ (10,826) $ (6,370) (1) Amounts reclassified are recorded in Net sales, Cost of sales, or Other non-operating income (expense), net on the Condensed Consolidated Statements of Operations. Refer to Note 13 for further information regarding classifications. The following table sets forth the changes in Accumulated other comprehensive loss for three months ended September 30, 2019: (in thousands) Unrealized losses on available-for-sale securities Unrealized holding gains (losses) on derivative transactions Foreign currency translation adjustments Total Balance at June 30, 2019 $ (4) $ 11,317 $ (12,611) $ (1,298) Other comprehensive income (loss) before reclassifications — 6,315 (8,389) (2,074) Amounts reclassified from accumulated other comprehensive loss (1) — (3,901) — (3,901) Net other comprehensive income (loss) during the period — 2,414 (8,389) (5,975) Balance at September 30, 2019 $ (4) $ 13,731 $ (21,000) $ (7,273) (1) Amounts reclassified are recorded in Net sales or Cost of sales on the Condensed Consolidated Statements of Operations. Refer to Note 13 for further information regarding classifications. The following table sets forth the changes in Accumulated other comprehensive loss for the nine months ended September 30, 2020: (in thousands) Unrealized losses on available-for-sale securities Unrealized holding gains (losses) on derivative transactions Foreign currency translation adjustments Total Balance at December 31, 2019 $ (4) $ 9,482 $ (13,903) $ (4,425) Other comprehensive income before reclassifications — 4,617 3,077 7,694 Amounts reclassified from accumulated other comprehensive loss (1) — (9,639) — (9,639) Net other comprehensive income (loss) during the period — (5,022) 3,077 (1,945) Balance at September 30, 2020 $ (4) $ 4,460 $ (10,826) $ (6,370) (1) Amounts reclassified are recorded in Net sales, Cost of sales, or Other non-operating income (expense), net on the Condensed Consolidated Statements of Operations. Refer to Note 13 for further information regarding classifications. The following table sets forth the changes in Accumulated other comprehensive loss for the nine months ended September 30, 2019: (in thousands) Unrealized gains (losses) on available-for-sale securities Unrealized holding gains (losses) on derivative transactions Foreign currency translation adjustments Total Balance at December 31, 2018 $ (60) $ 11,964 $ (15,967) $ (4,063) Other comprehensive income (loss) before reclassifications 56 9,119 (5,033) 4,142 Amounts reclassified from accumulated other comprehensive loss (1) — (7,253) — (7,253) Net other comprehensive income (loss) during the period 56 1,866 (5,033) (3,111) Purchase of non-controlling interest — (99) — (99) Balance at September 30, 2019 $ (4) $ 13,731 $ (21,000) $ (7,273)

Segment Information

Segment Information	9 Months Ended
	Sep. 30, 2020
Segment Reporting, Measurement Disclosures [Abstract]
Segment Information	NOTE 12—SEGMENT INFORMATION The Company has four reportable geographic segments: U.S., LAAP, EMEA, and Canada, which are reflective of the Company's internal organization, management and oversight structure. Each geographic segment operates predominantly in one industry: the design, development, marketing, and distribution of outdoor, active and everyday lifestyle apparel, footwear, accessories, and equipment products. Intersegment net sales and intersegment profits, which are recorded at a negotiated mark-up and eliminated in consolidation, are not material. Unallocated corporate expenses consist of expenses incurred by centrally-managed departments, including global information systems, finance, human resources and legal, as well as executive compensation, unallocated benefit program expense, and other miscellaneous costs. The geographic distribution of the Company's Net sales and Income from operations in the Condensed Consolidated Statements of Operations are summarized in the following table for the three and nine months ended September 30, 2020 and 2019. Three Months Ended September 30, Nine Months Ended September 30, (in thousands) 2020 2019 2020 2019 Net sales to unrelated entities: U.S. $ 445,620 $ 581,263 $ 1,004,733 $ 1,309,014 LAAP 90,951 123,246 260,912 357,719 EMEA 99,159 104,403 213,298 267,278 Canada 65,362 97,881 106,988 153,600 $ 701,092 $ 906,793 $ 1,585,931 $ 2,087,611 Segment income from operations: U.S. $ 96,577 $ 156,190 $ 118,454 $ 298,366 LAAP 4,736 17,081 8,690 53,822 EMEA 18,959 18,162 19,032 36,905 Canada 19,767 27,024 15,142 30,417 Total segment income from operations 140,039 218,457 161,318 419,510 Unallocated corporate expenses (54,396) (66,442) (147,962) (163,172) Interest income (expense), net (280) 1,399 728 7,370 Other non-operating income (expense), net (465) (563) 2,208 915 Income before income tax $ 84,898 $ 152,851 $ 16,292 $ 264,623 Concentrations The Company had one customer that accounted for 11.4% of Accounts receivable, net of allowance on the Condensed Consolidated Balance Sheets as of September 30, 2020. The Company had one customer that accounted for 13.9% of Accounts receivable, net of allowance as of December 31, 2019. No single customer accounted for 10% or more of Accounts receivable, net of allowance as of September 30, 2019. No single customer accounted for 10% or more of Net sales

Financial Instruments And Risk

Financial Instruments And Risk Management	9 Months Ended
	Sep. 30, 2020
Derivative Instruments and Hedges, Assets [Abstract]
Financial Instruments And Risk Management	In the normal course of business, the Company's financial position, results of operations and cash flows are routinely subject to a variety of risks. These risks include risks associated with financial markets, primarily currency exchange rate risk and, to a lesser extent, interest rate risk and equity market risk. The Company regularly assesses these risks and has established policies and business practices designed to mitigate them. The Company does not engage in speculative trading in any financial market. The Company actively manages the risk of changes in functional currency equivalent cash flows resulting from anticipated non-functional currency denominated purchases and sales. Subsidiaries that use European euros, Canadian dollars, Japanese yen, Chinese renminbi, or Korean won as their functional currency are primarily exposed to changes in functional currency equivalent cash flows from anticipated United States dollar inventory purchases. Subsidiaries that use United States dollars and euros as their functional currency also have non-functional currency denominated sales for which the Company hedges the Canadian dollar and Great British pound. The Company manages these risks by using currency forward contracts formally designated and effective as cash flow hedges. Hedge effectiveness is generally determined by evaluating the ability of a hedging instrument's cumulative change in fair value to offset the cumulative change in the present value of expected cash flows on the underlying exposures. For forward contracts, prior to June 2019, the time value components ("forward points") were excluded from the determination of hedge effectiveness and included in current period Cost of sales for hedges of anticipated United States dollar inventory purchases and in Net sales for hedges of anticipated non-functional currency denominated sales on a straight-line basis over the life of the contract. Effective June 2019, the forward points are included in the fair value of the cash flow hedge on a prospective basis. These costs or benefits will be included in Accumulated other comprehensive loss until the underlying hedge transaction is recognized in either Net sales or Cost of sales , at which time the forward points will also be recognized as a component of Net income . The Company also uses currency forward contracts not formally designated as hedges to manage the consolidated currency exchange rate risk associated with the remeasurement of non-functional currency denominated monetary assets and liabilities by subsidiaries that use United States dollars, euros, Canadian dollars, yen, won, or renminbi as their functional currency. Non-functional currency denominated monetary assets and liabilities consist primarily of cash and cash equivalents, short-term investments, receivables, payables, deferred income taxes, and intercompany loans. The gains and losses generated on these currency forward contracts not formally designated as hedges are expected to be largely offset in Other non-operating income (expense), net by the gains and losses generated from the remeasurement of the non-functional currency denominated monetary assets and liabilities. The following table presents the gross notional amount of outstanding derivative instruments: (in thousands) September 30, December 31, September 30, Derivative instruments designated as cash flow hedges: Currency forward contracts $ 419,402 $ 471,822 $ 412,041 Derivative instruments not designated as cash flow hedges: Currency forward contracts 224,573 214,086 235,945 At September 30, 2020, $5.1 million of deferred net gains on both outstanding and matured derivatives recorded in Other comprehensive loss are expected to be reclassified to Net income during the next twelve months as a result of underlying hedged transactions also being recorded in Net sales or Cost of sales in the Condensed Consolidated Statements of Operations. Actual amounts ultimately reclassified to Net sales or Cost of sales in the Condensed Consolidated Statements of Comprehensive Income are dependent on United States dollar exchange rates in effect against the euro, pound sterling, renminbi, Canadian dollar, and yen when outstanding derivative contracts mature. At September 30, 2020, the Company's derivative contracts had a remaining maturity of less than four years. The maximum net exposure to any single counterparty, which is generally limited to the aggregate unrealized gain of all contracts with that counterparty, was $2.9 million at September 30, 2020. All of the Company's derivative counterparties have credit ratings that are investment grade or higher. The Company is a party to master netting arrangements that contain features that allow counterparties to net settle amounts arising from multiple separate derivative transactions or net settle amounts arising from multiple separate derivative transactions or net settle in the case of certain triggering events such as a bankruptcy or major default of one of the counterparties to the transaction. The Company has not pledged assets or posted collateral as a requirement for entering into or maintaining derivative positions. The following table presents the balance sheet classification and fair value of derivative instruments: (in thousands) Balance Sheet Classification September 30, December 31, September 30, Derivative instruments designated as cash flow hedges: Derivative instruments in asset positions: Currency forward contracts Prepaid expenses and other current assets $ 4,729 $ 11,855 $ 16,603 Currency forward contracts Other non-current assets 3,454 4,159 4,830 Derivative instruments in liability positions: Currency forward contracts Accrued liabilities 2,034 1,313 201 Currency forward contracts Other long-term liabilities 1,186 768 109 Derivative instruments not designated as cash flow hedges: Derivative instruments in asset positions: Currency forward contracts Prepaid expenses and other current assets 2,211 2,146 1,857 Derivative instruments in liability positions: Currency forward contracts Accrued liabilities 381 953 320 The following table presents the statement of operations effect and classification of derivative instruments: Statement of Three Months Ended September 30, Nine Months Ended September 30, (in thousands) 2020 2019 2020 2019 Currency Forward and Option Contracts: Derivative instruments designated as cash flow hedges: Gain (loss) recognized in other comprehensive loss, net of tax — $ (6,398) $ 6,315 $ 4,617 $ 9,119 Gain reclassified from accumulated other comprehensive income or loss to income for the effective portion Net sales 80 172 123 282 Gain reclassified from accumulated other comprehensive income or loss to income for the effective portion Cost of sales 6,906 5,087 11,527 7,208 Gain reclassified from accumulated other comprehensive income or loss to income as a result of cash flow hedge discontinuance Other non-operating income (expense), net 60 — 1,177 — Loss recognized in income for amount excluded from effectiveness testing and for the ineffective portion Net sales — — — (31) Gain recognized in income for amount excluded from effectiveness testing and for the ineffective portion Cost of sales — — — 2,380 Derivative instruments not designated as cash flow hedges: Gain (loss) recognized in income Other non-operating income (expense), net (1,795) 1,855 (465) 1,281

Fair Value Measures

Fair Value Measures	9 Months Ended
	Sep. 30, 2020
Fair Value Disclosures [Abstract]
Fair Value Measures	Certain assets and liabilities are reported at fair value on either a recurring or nonrecurring basis. Fair value is defined as an exit price, representing the amount that the Company would receive to sell an asset or pay to transfer a liability in an orderly transaction between market participants, under a three-tier fair value hierarchy that prioritizes the inputs used in measuring fair value as follows: Level 1 — observable inputs such as quoted prices for identical assets or liabilities in active liquid markets; Level 2 — inputs, other than the quoted market prices in active markets, that are observable, either directly or indirectly; or observable market prices in markets with insufficient volume or infrequent transactions; and Level 3 — unobservable inputs for which there is little or no market data available, that require the reporting entity to develop its own assumptions. The Company's assets and liabilities measured at fair value are categorized as Level 1 or Level 2 instruments. Level 1 instrument valuations are obtained from real-time quotes for transactions in active exchange markets involving identical assets. Level 2 instrument valuations are obtained from inputs, other than quoted market prices in active markets, that are directly or indirectly observable in the marketplace and quoted prices in markets with limited volume or infrequent transactions. Assets and liabilities measured at fair value on a recurring basis as of September 30, 2020 were as follows: (in thousands) Level 1 Level 2 Level 3 Total Assets: Cash equivalents: Money market funds $ 56,337 $ — $ — $ 56,337 Other short-term investments: Money market funds 70 — — 70 Mutual fund shares 1,025 — — 1,025 Other current assets: Derivative financial instruments — 6,940 — 6,940 Other non-current assets: Money market funds 4,621 — — 4,621 Mutual fund shares 11,974 — — 11,974 Derivative financial instruments — 3,454 — 3,454 Total assets measured at fair value $ 74,027 $ 10,394 $ — $ 84,421 Liabilities: Accrued liabilities: Derivative financial instruments $ — $ 2,415 $ — $ 2,415 Other long-term liabilities: Derivative financial instruments — 1,186 — 1,186 Total liabilities measured at fair value $ — $ 3,601 $ — $ 3,601 Assets and liabilities measured at fair value on a recurring basis as of December 31, 2019 were as follows: (in thousands) Level 1 Level 2 Level 3 Total Assets: Cash equivalents: Money market funds $ 288,926 $ — $ — $ 288,926 United States government treasury bills — 34,928 — 34,928 Commercial paper — 33,587 — 33,587 Other short-term investments: Mutual fund shares 1,668 — — 1,668 Other current assets: Derivative financial instruments — 14,001 — 14,001 Other non-current assets: Money market funds 1,792 — — 1,792 Mutual fund shares 12,172 — — 12,172 Derivative financial instruments — 4,159 — 4,159 Total assets measured at fair value $ 304,558 $ 86,675 $ — $ 391,233 Liabilities: Accrued liabilities: Derivative financial instruments $ — $ 2,266 $ — $ 2,266 Other long-term liabilities: Derivative financial instruments — 768 — 768 Total liabilities measured at fair value $ — $ 3,034 $ — $ 3,034 Assets and liabilities measured at fair value on a recurring basis as of September 30, 2019 were as follows: (in thousands) Level 1 Level 2 Level 3 Total Assets: Cash equivalents: Money market funds $ 72,941 $ — $ — $ 72,941 Other short-term investments: Mutual funds shares 1,477 — — 1,477 Other current assets: Derivative financial instruments — 18,460 — 18,460 Other non-current assets: Money market funds 1,528 — — 1,528 Mutual fund shares 11,362 — — 11,362 Derivative financial instruments — 4,830 — 4,830 Total assets measured at fair value $ 87,308 $ 23,290 $ — $ 110,598 Liabilities: Accrued liabilities: Derivative financial instruments $ — $ 521 $ — $ 521 Other long-term liabilities: Derivative financial instruments — 109 — 109 Total liabilities measured at fair value $ — $ 630 $ — $ 630

Basis Of Presentation And Org_2

Basis Of Presentation And Organization Estimates and Assumptions (Policies)	3 Months Ended	9 Months Ended
	Sep. 30, 2020	Sep. 30, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Principles of Consolidation		Principles of Consolidation The condensed consolidated financial statements include the accounts of Columbia Sportswear Company and its wholly owned subsidiaries. All significant intercompany balances and transactions have been eliminated in consolidation.
Estimates and Assumptions	Estimates and Assumptions The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results may differ from these estimates and assumptions. Some of the more significant estimates relate to revenue recognition, allowance for uncollectible accounts receivable, excess, close-out and slow moving inventory, product warranty, impairment of long-lived assets, intangible assets and goodwill, income taxes, and stock-based compensation. COVID-19 A novel strain of coronavirus ("COVID-19") was first identified in China in December 2019 and a global pandemic of respiratory disease caused by COVID-19 was declared by the World Health Organization in March 2020. The current environment of uncertainty significantly affected the September 30, 2020 estimates for allowance for uncollectible accounts receivable and excess, close-out and slow-moving inventory. These estimates involve assumptions about future events. The allowance for uncollectible accounts receivable includes assumptions about the future financial condition of the Company's customers and their ability to make required payments. The provision for excess, close-out and slow moving inventory includes assumptions about future demand for the Company’s products and the Company's ability to sell them at a profit. As a result of lower consumer demand related to the COVID-19 pandemic, the Company tested certain retail locations and their respective lease right-of-use assets for impairment. For the three and nine months ended September 30, 2020, impairment charges for certain underperforming retail stores were $0.1 million and $6.7 million, respectively. These charges were recognized in Selling, general and administrative expenses (" SG&A expense "). Additionally, as a result of the COVID-19 pandemic and a significant decline in projected net sales, the prAna brand's trademark and goodwill were tested for impairment as of March 31, 2020. While no impairment was indicated during the first quarter 2020 tests, the degree by which the fair value of the prAna reporting unit and trademark exceeded their respective carrying values declined from the Company's 2019 impairment test. After performing both qualitative and quantitative analysis, including review of future long-term revenue and cash flow assumptions, the Company concluded a triggering event requiring measurement of the prAna brand's trademark and goodwill for impairment during the quarter ended September 30, 2020 did not occur. As of September 30, 2020, the Company received or negotiated lease concessions related to the effects of the COVID-19 pandemic on a portion of its stores. In April 2020, the Financial Accounting Standards Board (“FASB”) issued a Staff Q&A, Topic 842 and 840: Accounting for Lease Concessions Related to the Effects of the COVID-19 Pandemic. The FASB staff indicated that it would be acceptable for entities to make an election to account for lease concessions related to the effects of the COVID-19 pandemic consistent with how they would be accounted for as though enforceable rights and obligations for those concessions existed in the original contract. The Company elected to account for lease concessions related to the effects of the COVID-19 pandemic in accordance with the Staff Q&A. For concessions that provide a deferral of payments with no substantive changes to the consideration in the original contract, the Company continues to recognize In response to the COVID-19 pandemic, the Coronavirus Aid, Relief, and Economic Security Act (the “CARES Act”) was signed into law in the United States on March 27, 2020. The CARES Act provides payroll tax credits for employee retention, deferral of payroll tax payments and several income tax provision modifications. Additionally, there are other subsidies and incentives provided by foreign governments in the countries where the Company conducts business. For the three and nine months ended September 30, 2020, $2.8 million and $7.1 million, respectively, of government subsidies and incentives reduced SG&A expense
Recently Adopted Accounting Pronouncements and Not Yet Adopted		Recently Adopted Accounting Pronouncements Effective January 1, 2020, the Company adopted Accounting Standards Update ("ASU") No. 2018-15, Intangibles - Goodwill and Other - Internal-Use Software (Subtopic 350-40) issued by the FASB in August 2018, which clarifies certain aspects of accounting for implementation costs incurred in a cloud computing arrangement ("CCA") that is a service contract. Under the ASU, an entity would expense costs incurred in the preliminary-project and post-implementation-operation stages. The entity would also capitalize certain costs incurred during the application-development stage, as well as certain costs related to enhancements. The ASU does not change the accounting for the service component of a CCA. The Company adopted the standard using the prospective method and anticipates an increase in cloud-specific implementation assets as specific cloud initiatives are executed by the Company. These assets will generally be included in Other non-current assets in the Condensed Consolidated Balance Sheets and will amortize over their assessed useful lives or the term of the underlying cloud computing hosting contract, whichever is shorter. Upon the adoption of the standard, there was no immediate impact to the Company's financial position, results of operations or cash flows. Effective January 1, 2020, the Company adopted ASU No. 2017-04, Intangibles - Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment issued by the FASB in January 2017, which simplifies the accounting for goodwill impairments by eliminating step two from the goodwill impairment test. Under this guidance, if the carrying amount of a reporting unit exceeds its estimated fair value, an impairment charge shall be recognized in an amount equal to that excess, limited to the total amount of goodwill allocated to that reporting unit. The impact of the new standard will depend on the specific facts and circumstances of future individual goodwill impairments, if any. Effective January 1, 2020, the Company adopted ASU No. 2016-13, Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments issued by the FASB in June 2016, as well as the clarifying amendments subsequently issued. The pronouncement changes the impairment model for most financial assets and will require the use of an "expected loss" model for instruments measured at amortized cost. Under this model, entities will be required to estimate the lifetime expected credit loss on such instruments and record an allowance to offset the amortized cost basis of the financial asset, resulting in a net presentation of the amount expected to be collected on the financial asset. Upon adoption of the standard, there was no immediate impact to the Company's financial position, results of operations or cash flows. On an ongoing basis, the Company will contemplate forward-looking economic conditions in recording lifetime expected credit losses for the Company’s financial assets measured at cost, such as the Company’s trade receivables and certain short-term investments. Summary of Significant Accounting Policies Except as disclosed below, there have been no significant changes to the Company's significant accounting policies as described in Note 2 in the Company's Annual Report on Form 10-K for the year ended December 31, 2019. The following significant accounting policies have been updated since the Company’s 2019 Annual Report on Form 10-K as a result of the adoption of ASU No. 2016-13 and ASU No. 2018-15, respectively: Accounts Receivable Accounts receivable have been reduced by an allowance for doubtful accounts. The Company maintains the allowance for estimated losses resulting from the inability of the Company's customers to make required payments. The allowance represents the current estimate of lifetime expected credit losses over the remaining duration of existing accounts receivable considering current market conditions and supportable forecasts when appropriate. The estimate is a result of the Company’s ongoing evaluation of collectability, customer creditworthiness, historical levels of credit losses, and future expectations. Write-off activity and recoveries for the periods presented were not material. Cloud Computing Arrangements The Company’s CCAs primarily relate to various enterprise resource planning systems, as well as other supporting systems. These assets are generally included in Other non-current assets in the Condensed Consolidated Balance Sheets and amortize on a straight-line basis over their assessed useful lives or the term of the underlying cloud computing hosting contract, whichever is shorter. As of September 30, 2020, assets were in-service with useful lives ranging from ten months to five years. As of September 30, 2020, CCA assets consisted of capitalized implementation costs of $24.1 million and associated accumulated amortization of $0.7 million. Changes in these assets are recorded in Other assets within operating activities in the Condensed Consolidated Statements of Cash Flows. In December 2019, the FASB issued ASU No. 2019-12 ,

Revenues (Tables)

Revenues (Tables)	9 Months Ended
	Sep. 30, 2020
Revenue from Contract with Customer [Abstract]
Schedule of Disaggregation of Revenue	The following tables disaggregate the Company's operating segment Net sales by product category and sales channel, which the Company believes provide a meaningful depiction of how the nature, timing, and uncertainty of Net sales are affected by economic factors: Three Months Ended September 30, 2020 (in thousands) U.S. LAAP EMEA Canada Total Product category net sales Apparel, Accessories and Equipment $ 332,713 $ 70,026 $ 66,160 $ 41,221 $ 510,120 Footwear 112,907 20,925 32,999 24,141 190,972 Total $ 445,620 $ 90,951 $ 99,159 $ 65,362 $ 701,092 Sales channel net sales Wholesale $ 282,850 $ 50,723 $ 85,074 $ 52,820 $ 471,467 Direct-to-consumer 162,770 40,228 14,085 12,542 229,625 Total $ 445,620 $ 90,951 $ 99,159 $ 65,362 $ 701,092 Three Months Ended September 30, 2019 (in thousands) U.S. LAAP EMEA Canada Total Product category net sales Apparel, Accessories and Equipment $ 459,633 $ 93,486 $ 66,058 $ 65,532 $ 684,709 Footwear 121,630 29,760 38,345 32,349 222,084 Total $ 581,263 $ 123,246 $ 104,403 $ 97,881 $ 906,793 Sales channel net sales Wholesale $ 396,275 $ 77,934 $ 91,329 $ 86,993 $ 652,531 Direct-to-consumer 184,988 45,312 13,074 10,888 254,262 Total $ 581,263 $ 123,246 $ 104,403 $ 97,881 $ 906,793 Nine months ended September 30, 2020 (in thousands) U.S. LAAP EMEA Canada Total Product category net sales Apparel, Accessories and Equipment $ 793,846 $ 193,815 $ 145,100 $ 73,445 $ 1,206,206 Footwear 210,887 67,097 68,198 33,543 379,725 Total $ 1,004,733 $ 260,912 $ 213,298 $ 106,988 $ 1,585,931 Sales channel net sales Wholesale $ 559,052 $ 139,316 $ 180,416 $ 78,546 $ 957,330 Direct-to-consumer 445,681 121,596 32,882 28,442 628,601 Total $ 1,004,733 $ 260,912 $ 213,298 $ 106,988 $ 1,585,931 Nine Months Ended September 30, 2019 (in thousands) U.S. LAAP EMEA Canada Total Product category net sales Apparel, Accessories and Equipment $ 1,081,942 $ 267,919 $ 183,168 $ 109,909 $ 1,642,938 Footwear 227,072 89,800 84,110 43,691 444,673 Total $ 1,309,014 $ 357,719 $ 267,278 $ 153,600 $ 2,087,611 Sales channel net sales Wholesale $ 756,558 $ 200,083 $ 231,219 $ 124,119 $ 1,311,979 Direct-to-consumer 552,456 157,636 36,059 29,481 775,632 Total $ 1,309,014 $ 357,719 $ 267,278 $ 153,600 $ 2,087,611

Intangible Assets, Net (Tables)

Intangible Assets, Net (Tables)	9 Months Ended
	Sep. 30, 2020
Goodwill and Intangible Assets Disclosure [Abstract]
Summary Of Identifiable Intangible Assets	Intangible assets, net consisted of the following: (in thousands) September 30, December 31, September 30, Intangible assets subject to amortization: Patents and purchased technology $ 14,198 $ 14,198 $ 14,198 Customer relationships 23,000 23,000 23,000 Gross carrying amount 37,198 37,198 37,198 Accumulated amortization: Patents and purchased technology (14,198) (13,311) (12,979) Customer relationships (16,950) (15,713) (15,300) Total accumulated amortization (31,148) (29,024) (28,279) Net carrying amount 6,050 8,174 8,919 Intangible assets not subject to amortization 115,421 115,421 115,421 Intangible assets, net $ 121,471 $ 123,595 $ 124,340
Schedule of finite lived intangible assets future amortization expense	Annual amortization expense is estimated to be as follows for the years 2020 through 2024: (in thousands) 2020 $ 2,537 2021 1,650 2022 1,650 2023 1,650 2024 688

Product Warranty (Tables)

Product Warranty (Tables)	9 Months Ended
	Sep. 30, 2020
Product Warranties Disclosures [Abstract]
Reconciliation Of Product Warranties	A reconciliation of product warranties is as follows: Three Months Ended September 30, Nine Months Ended September 30, (in thousands) 2020 2019 2020 2019 Balance at beginning of period $ 13,334 $ 13,186 $ 14,466 $ 13,186 Provision for warranty claims 525 645 1,430 3,140 Warranty claims (493) (440) (2,378) (2,899) Other 175 (180) 23 (216) Balance at end of period $ 13,541 $ 13,211 $ 13,541 $ 13,211

Stock-Based Compensation (Table

Stock-Based Compensation (Tables)	9 Months Ended
	Sep. 30, 2020
Share-based Payment Arrangement, Noncash Expense [Abstract]
Share-based Compensation Arrangements by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding [Table Text Block]	Stock-based compensation expense consisted of the following: Three Months Ended September 30, Nine Months Ended September 30, (in thousands) 2020 2019 2020 2019 Stock options $ 1,775 $ 1,509 $ 5,234 $ 4,600 Restricted stock units 3,315 2,869 7,568 8,559 Total $ 5,090 $ 4,378 $ 12,802 $ 13,159

Earnings Per Share (Tables)

Earnings Per Share (Tables)	9 Months Ended
	Sep. 30, 2020
Earnings Per Share [Abstract]
Reconciliation Of Common Shares Used In Denominator For Computing Basic And Diluted EPS	A reconciliation of common shares used in the denominator for computing basic and diluted EPS is as follows: Three Months Ended September 30, Nine Months Ended September 30, (in thousands, except per share amounts) 2020 2019 2020 2019 Weighted average shares of common stock outstanding, used in computing basic earnings per share 66,179 67,593 66,427 67,935 Effect of dilutive stock options and restricted stock units 358 587 380 685 Weighted average shares of common stock outstanding, used in computing diluted earnings per share 66,537 68,180 66,807 68,620 Earnings per share of common stock: Basic $ 0.95 $ 1.76 $ 0.18 $ 3.19 Diluted $ 0.94 $ 1.75 $ 0.18 $ 3.15

Accumulated Other Comprehensi_2

Accumulated Other Comprehensive Income (Tables)	9 Months Ended
	Sep. 30, 2020
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]
Accumulated Other Comprehensive Income, Net Of Related Tax Effects	The following table sets forth the changes in Accumulated other comprehensive loss for the three months ended September 30, 2020: (in thousands) Unrealized losses on available-for-sale securities Unrealized holding gains (losses) on derivative transactions Foreign currency translation adjustments Total Balance at June 30, 2020 $ (4) $ 16,145 $ (22,001) $ (5,860) Other comprehensive income (loss) before reclassifications — (6,398) 11,175 4,777 Amounts reclassified from accumulated other comprehensive loss (1) — (5,287) — (5,287) Net other comprehensive income (loss) during the period — (11,685) 11,175 (510) Balance at September 30, 2020 $ (4) $ 4,460 $ (10,826) $ (6,370) (1) Amounts reclassified are recorded in Net sales, Cost of sales, or Other non-operating income (expense), net on the Condensed Consolidated Statements of Operations. Refer to Note 13 for further information regarding classifications. The following table sets forth the changes in Accumulated other comprehensive loss for three months ended September 30, 2019: (in thousands) Unrealized losses on available-for-sale securities Unrealized holding gains (losses) on derivative transactions Foreign currency translation adjustments Total Balance at June 30, 2019 $ (4) $ 11,317 $ (12,611) $ (1,298) Other comprehensive income (loss) before reclassifications — 6,315 (8,389) (2,074) Amounts reclassified from accumulated other comprehensive loss (1) — (3,901) — (3,901) Net other comprehensive income (loss) during the period — 2,414 (8,389) (5,975) Balance at September 30, 2019 $ (4) $ 13,731 $ (21,000) $ (7,273) (1) Amounts reclassified are recorded in Net sales or Cost of sales on the Condensed Consolidated Statements of Operations. Refer to Note 13 for further information regarding classifications. The following table sets forth the changes in Accumulated other comprehensive loss for the nine months ended September 30, 2020: (in thousands) Unrealized losses on available-for-sale securities Unrealized holding gains (losses) on derivative transactions Foreign currency translation adjustments Total Balance at December 31, 2019 $ (4) $ 9,482 $ (13,903) $ (4,425) Other comprehensive income before reclassifications — 4,617 3,077 7,694 Amounts reclassified from accumulated other comprehensive loss (1) — (9,639) — (9,639) Net other comprehensive income (loss) during the period — (5,022) 3,077 (1,945) Balance at September 30, 2020 $ (4) $ 4,460 $ (10,826) $ (6,370) (1) Amounts reclassified are recorded in Net sales, Cost of sales, or Other non-operating income (expense), net on the Condensed Consolidated Statements of Operations. Refer to Note 13 for further information regarding classifications. The following table sets forth the changes in Accumulated other comprehensive loss for the nine months ended September 30, 2019: (in thousands) Unrealized gains (losses) on available-for-sale securities Unrealized holding gains (losses) on derivative transactions Foreign currency translation adjustments Total Balance at December 31, 2018 $ (60) $ 11,964 $ (15,967) $ (4,063) Other comprehensive income (loss) before reclassifications 56 9,119 (5,033) 4,142 Amounts reclassified from accumulated other comprehensive loss (1) — (7,253) — (7,253) Net other comprehensive income (loss) during the period 56 1,866 (5,033) (3,111) Purchase of non-controlling interest — (99) — (99) Balance at September 30, 2019 $ (4) $ 13,731 $ (21,000) $ (7,273)

Segment Information (Tables)

Segment Information (Tables)	9 Months Ended
	Sep. 30, 2020
Segment Reporting, Measurement Disclosures [Abstract]
Schedule Of Segment Information	The geographic distribution of the Company's Net sales and Income from operations in the Condensed Consolidated Statements of Operations are summarized in the following table for the three and nine months ended September 30, 2020 and 2019. Three Months Ended September 30, Nine Months Ended September 30, (in thousands) 2020 2019 2020 2019 Net sales to unrelated entities: U.S. $ 445,620 $ 581,263 $ 1,004,733 $ 1,309,014 LAAP 90,951 123,246 260,912 357,719 EMEA 99,159 104,403 213,298 267,278 Canada 65,362 97,881 106,988 153,600 $ 701,092 $ 906,793 $ 1,585,931 $ 2,087,611 Segment income from operations: U.S. $ 96,577 $ 156,190 $ 118,454 $ 298,366 LAAP 4,736 17,081 8,690 53,822 EMEA 18,959 18,162 19,032 36,905 Canada 19,767 27,024 15,142 30,417 Total segment income from operations 140,039 218,457 161,318 419,510 Unallocated corporate expenses (54,396) (66,442) (147,962) (163,172) Interest income (expense), net (280) 1,399 728 7,370 Other non-operating income (expense), net (465) (563) 2,208 915 Income before income tax $ 84,898 $ 152,851 $ 16,292 $ 264,623

Financial Instruments And Ris_2

Financial Instruments And Risk Management (Tables)	9 Months Ended
	Sep. 30, 2020
Derivative Instruments and Hedges, Assets [Abstract]
Gross Notional Amount Of Outstanding Derivative Instruments	The following table presents the gross notional amount of outstanding derivative instruments: (in thousands) September 30, December 31, September 30, Derivative instruments designated as cash flow hedges: Currency forward contracts $ 419,402 $ 471,822 $ 412,041 Derivative instruments not designated as cash flow hedges: Currency forward contracts 224,573 214,086 235,945
Balance Sheet Classification And Fair Value Of Derivative Instruments	The following table presents the balance sheet classification and fair value of derivative instruments: (in thousands) Balance Sheet Classification September 30, December 31, September 30, Derivative instruments designated as cash flow hedges: Derivative instruments in asset positions: Currency forward contracts Prepaid expenses and other current assets $ 4,729 $ 11,855 $ 16,603 Currency forward contracts Other non-current assets 3,454 4,159 4,830 Derivative instruments in liability positions: Currency forward contracts Accrued liabilities 2,034 1,313 201 Currency forward contracts Other long-term liabilities 1,186 768 109 Derivative instruments not designated as cash flow hedges: Derivative instruments in asset positions: Currency forward contracts Prepaid expenses and other current assets 2,211 2,146 1,857 Derivative instruments in liability positions: Currency forward contracts Accrued liabilities 381 953 320 The following table presents the statement of operations effect and classification of derivative instruments: Statement of Three Months Ended September 30, Nine Months Ended September 30, (in thousands) 2020 2019 2020 2019 Currency Forward and Option Contracts: Derivative instruments designated as cash flow hedges: Gain (loss) recognized in other comprehensive loss, net of tax — $ (6,398) $ 6,315 $ 4,617 $ 9,119 Gain reclassified from accumulated other comprehensive income or loss to income for the effective portion Net sales 80 172 123 282 Gain reclassified from accumulated other comprehensive income or loss to income for the effective portion Cost of sales 6,906 5,087 11,527 7,208 Gain reclassified from accumulated other comprehensive income or loss to income as a result of cash flow hedge discontinuance Other non-operating income (expense), net 60 — 1,177 — Loss recognized in income for amount excluded from effectiveness testing and for the ineffective portion Net sales — — — (31) Gain recognized in income for amount excluded from effectiveness testing and for the ineffective portion Cost of sales — — — 2,380 Derivative instruments not designated as cash flow hedges: Gain (loss) recognized in income Other non-operating income (expense), net (1,795) 1,855 (465) 1,281

Fair Value Measures (Tables)

Fair Value Measures (Tables)	9 Months Ended
	Sep. 30, 2020
Fair Value Disclosures [Abstract]
Assets And Liabilities Measured At Fair Value On A Recurring Basis	Assets and liabilities measured at fair value on a recurring basis as of September 30, 2020 were as follows: (in thousands) Level 1 Level 2 Level 3 Total Assets: Cash equivalents: Money market funds $ 56,337 $ — $ — $ 56,337 Other short-term investments: Money market funds 70 — — 70 Mutual fund shares 1,025 — — 1,025 Other current assets: Derivative financial instruments — 6,940 — 6,940 Other non-current assets: Money market funds 4,621 — — 4,621 Mutual fund shares 11,974 — — 11,974 Derivative financial instruments — 3,454 — 3,454 Total assets measured at fair value $ 74,027 $ 10,394 $ — $ 84,421 Liabilities: Accrued liabilities: Derivative financial instruments $ — $ 2,415 $ — $ 2,415 Other long-term liabilities: Derivative financial instruments — 1,186 — 1,186 Total liabilities measured at fair value $ — $ 3,601 $ — $ 3,601 Assets and liabilities measured at fair value on a recurring basis as of December 31, 2019 were as follows: (in thousands) Level 1 Level 2 Level 3 Total Assets: Cash equivalents: Money market funds $ 288,926 $ — $ — $ 288,926 United States government treasury bills — 34,928 — 34,928 Commercial paper — 33,587 — 33,587 Other short-term investments: Mutual fund shares 1,668 — — 1,668 Other current assets: Derivative financial instruments — 14,001 — 14,001 Other non-current assets: Money market funds 1,792 — — 1,792 Mutual fund shares 12,172 — — 12,172 Derivative financial instruments — 4,159 — 4,159 Total assets measured at fair value $ 304,558 $ 86,675 $ — $ 391,233 Liabilities: Accrued liabilities: Derivative financial instruments $ — $ 2,266 $ — $ 2,266 Other long-term liabilities: Derivative financial instruments — 768 — 768 Total liabilities measured at fair value $ — $ 3,034 $ — $ 3,034 Assets and liabilities measured at fair value on a recurring basis as of September 30, 2019 were as follows: (in thousands) Level 1 Level 2 Level 3 Total Assets: Cash equivalents: Money market funds $ 72,941 $ — $ — $ 72,941 Other short-term investments: Mutual funds shares 1,477 — — 1,477 Other current assets: Derivative financial instruments — 18,460 — 18,460 Other non-current assets: Money market funds 1,528 — — 1,528 Mutual fund shares 11,362 — — 11,362 Derivative financial instruments — 4,830 — 4,830 Total assets measured at fair value $ 87,308 $ 23,290 $ — $ 110,598 Liabilities: Accrued liabilities: Derivative financial instruments $ — $ 521 $ — $ 521 Other long-term liabilities: Derivative financial instruments — 109 — 109 Total liabilities measured at fair value $ — $ 630 $ — $ 630

Basis Of Presentation And Org_3

Basis Of Presentation And Organization (Details) $ in Millions	3 Months Ended	9 Months Ended
	Sep. 30, 2020USD ($)	Sep. 30, 2020USD ($)
Property, Plant and Equipment [Line Items]
Other Asset Impairment Charges	$ 0.1	$ 6.7
Government Subsidies and Incentives	2.8	7.1
Hosting Arrangement, Service Contract, Implementation Cost, Capitalized, before Accumulated Amortization	24.1	24.1
Hosting Arrangement, Service Contract, Implementation Cost, Capitalized, Accumulated Amortization	$ 0.7	$ 0.7
Cloud Computing Arrangements | Minimum
Property, Plant and Equipment [Line Items]
Useful life		10 months
Cloud Computing Arrangements | Maximum
Property, Plant and Equipment [Line Items]
Useful life		5 years

Revenues (Details)

Revenues (Details) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2020USD ($)	Sep. 30, 2019USD ($)	Sep. 30, 2020USD ($)GeographicSegments	Sep. 30, 2019USD ($)
Disaggregation of Revenue [Line Items]
Number of Operating Segments | GeographicSegments			4
Revenue	$ 701,092	$ 906,793	$ 1,585,931	$ 2,087,611
Wholesale
Disaggregation of Revenue [Line Items]
Revenue	471,467	652,531	957,330	1,311,979
Direct-to-consumer
Disaggregation of Revenue [Line Items]
Revenue	229,625	254,262	628,601	775,632
U.S.
Disaggregation of Revenue [Line Items]
Revenue	445,620	581,263	1,004,733	1,309,014
U.S. | Wholesale
Disaggregation of Revenue [Line Items]
Revenue	282,850	396,275	559,052	756,558
U.S. | Direct-to-consumer
Disaggregation of Revenue [Line Items]
Revenue	162,770	184,988	445,681	552,456
LAAP
Disaggregation of Revenue [Line Items]
Revenue	90,951	123,246	260,912	357,719
LAAP | Wholesale
Disaggregation of Revenue [Line Items]
Revenue	50,723	77,934	139,316	200,083
LAAP | Direct-to-consumer
Disaggregation of Revenue [Line Items]
Revenue	40,228	45,312	121,596	157,636
EMEA
Disaggregation of Revenue [Line Items]
Revenue	99,159	104,403	213,298	267,278
EMEA | Wholesale
Disaggregation of Revenue [Line Items]
Revenue	85,074	91,329	180,416	231,219
EMEA | Direct-to-consumer
Disaggregation of Revenue [Line Items]
Revenue	14,085	13,074	32,882	36,059
Canada
Disaggregation of Revenue [Line Items]
Revenue	65,362	97,881	106,988	153,600
Canada | Wholesale
Disaggregation of Revenue [Line Items]
Revenue	52,820	86,993	78,546	124,119
Canada | Direct-to-consumer
Disaggregation of Revenue [Line Items]
Revenue	12,542	10,888	28,442	29,481
Apparel, Accessories and Equipment
Disaggregation of Revenue [Line Items]
Revenue	510,120	684,709	1,206,206	1,642,938
Apparel, Accessories and Equipment | U.S.
Disaggregation of Revenue [Line Items]
Revenue	332,713	459,633	793,846	1,081,942
Apparel, Accessories and Equipment | LAAP
Disaggregation of Revenue [Line Items]
Revenue	70,026	93,486	193,815	267,919
Apparel, Accessories and Equipment | EMEA
Disaggregation of Revenue [Line Items]
Revenue	66,160	66,058	145,100	183,168
Apparel, Accessories and Equipment | Canada
Disaggregation of Revenue [Line Items]
Revenue	41,221	65,532	73,445	109,909
Footwear
Disaggregation of Revenue [Line Items]
Revenue	190,972	222,084	379,725	444,673
Footwear | U.S.
Disaggregation of Revenue [Line Items]
Revenue	112,907	121,630	210,887	227,072
Footwear | LAAP
Disaggregation of Revenue [Line Items]
Revenue	20,925	29,760	67,097	89,800
Footwear | EMEA
Disaggregation of Revenue [Line Items]
Revenue	32,999	38,345	68,198	84,110
Footwear | Canada
Disaggregation of Revenue [Line Items]
Revenue	$ 24,141	$ 32,349	$ 33,543	$ 43,691

Intangible Assets, Net (Summary

Intangible Assets, Net (Summary Of Identifiable Intangible Assets) (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019	Dec. 31, 2019
Summary of Identifiable Intangible Assets [Line Items]
Intangible assets subject to amortization, Gross carrying amount	$ 37,198	$ 37,198	$ 37,198	$ 37,198	$ 37,198
Intangible assets subject to amortization, Accumulated amortization	(31,148)	(28,279)	(31,148)	(28,279)	(29,024)
Intangible assets subject to amortization, Net carrying amount	6,050	8,919	6,050	8,919	8,174
Intangible assets not subject to amortization	115,421	115,421	115,421	115,421	115,421
Intangible assets, net	121,471	124,340	121,471	124,340	123,595
Amortization of Intangible Assets	600	700	2,100	2,200
Patents And Purchased Technology [Member]
Summary of Identifiable Intangible Assets [Line Items]
Intangible assets subject to amortization, Gross carrying amount	14,198	14,198	14,198	14,198	14,198
Intangible assets subject to amortization, Accumulated amortization	(14,198)	(12,979)	(14,198)	(12,979)	(13,311)
Customer Relationships [Member]
Summary of Identifiable Intangible Assets [Line Items]
Intangible assets subject to amortization, Gross carrying amount	23,000	23,000	23,000	23,000	23,000
Intangible assets subject to amortization, Accumulated amortization	$ (16,950)	$ (15,300)	$ (16,950)	$ (15,300)	$ (15,713)

Intangible Assets, Net (Details

Intangible Assets, Net (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Goodwill and Intangible Assets Disclosure [Abstract]
Amortization of Intangible Assets	$ 0.6	$ 0.7	$ 2.1	$ 2.2

Intangible Assets, Net and Good

Intangible Assets, Net and Goodwill Schedule of Estimated Five Year Amortization Expense (Details) $ in Thousands	Sep. 30, 2020USD ($)
Goodwill and Intangible Assets Disclosure [Abstract]
2020	$ 2,537
2021	1,650
2022	1,650
2023	1,650
2024	$ 688

Short Term Borrowings and Cre_2

Short Term Borrowings and Credit Lines (Details)	Apr. 15, 2020USD ($)	Sep. 30, 2020USD ($)	Sep. 30, 2020CAD ($)	Sep. 30, 2020EUR (€)	Sep. 30, 2020JPY (¥)	Jul. 10, 2020USD ($)	Jul. 01, 2020USD ($)	Jul. 01, 2020JPY (¥)	Jun. 30, 2020USD ($)	Dec. 31, 2019USD ($)	Dec. 31, 2019EUR (€)
Variable Commitments Revolving Credit Facility | Line of Credit | Revolving Credit Facility
Debt Instrument [Line Items]
Maximum borrowing capacity										$ 50,000,000
Revolving Credit Facility, First Amendment | Line of Credit | Revolving Credit Facility
Debt Instrument [Line Items]
Maximum borrowing capacity									$ 125,000,000
Revolving A Loan | Line of Credit | Revolving Credit Facility
Debt Instrument [Line Items]
Maximum borrowing capacity	$ 125,000,000
Revolving B Loan | Line of Credit | Revolving Credit Facility
Debt Instrument [Line Items]
Maximum borrowing capacity	400,000,000
Line of credit facility, increase limit	$ 100,000,000
Revolving Loans | Revolving Credit Facility
Debt Instrument [Line Items]
Maximum borrowing capacity						$ 350,000,000
Revolving Loans | Minimum | Revolving Credit Facility
Debt Instrument [Line Items]
Debt instrument, covenant, liquidity requirement						$ 200,000,000
Revolving Loans | Line of Credit | Revolving Credit Facility
Debt Instrument [Line Items]
LIBOR floor interest rate						0.50%
Revolving Loans | Line of Credit | London Interbank Offered Rate (LIBOR) | Minimum | Revolving Credit Facility
Debt Instrument [Line Items]
Basis spread on variable rate	2.00%
Revolving Loans | Line of Credit | London Interbank Offered Rate (LIBOR) | Maximum | Revolving Credit Facility
Debt Instrument [Line Items]
Basis spread on variable rate	2.75%
Revolving Loans | Line of Credit | Base Rate | Minimum | Revolving Credit Facility
Debt Instrument [Line Items]
Basis spread on variable rate	1.00%
Revolving Loans | Line of Credit | Base Rate | Maximum | Revolving Credit Facility
Debt Instrument [Line Items]
Basis spread on variable rate	1.75%
Revolving Loans | Line of Credit | Fed Funds Effective Rate Overnight Index Swap Rate | Revolving Credit Facility
Debt Instrument [Line Items]
Basis spread on variable rate	1.50%
Canadian Subsidiary | Unsecured And Uncommitted Line Of Credit | Line of Credit
Debt Instrument [Line Items]
Maximum borrowing capacity		$ 22,400,000	$ 30,000,000
Amount outstanding		$ 0
Canadian Subsidiary | Unsecured And Uncommitted Line Of Credit | Line of Credit | Bankers' Acceptance Rate
Debt Instrument [Line Items]
Basis spread on variable rate		1.50%
European Subsidiary | Unsecured And Uncommitted Line Of Credit | Line of Credit
Debt Instrument [Line Items]
Maximum borrowing capacity | €				€ 600,000
Stated interest rate		0.75%	0.75%	0.75%	0.75%
European Subsidiary | Unsecured And Uncommitted Credit Line1 | Line of Credit
Debt Instrument [Line Items]
Maximum borrowing capacity | €				€ 25,800,000							€ 25,800,000
Stated interest rate		1.85%	1.85%	1.85%	1.85%
European Subsidiary | Unsecured And Uncommitted Credit Line1 | Line of Credit | Base Rate
Debt Instrument [Line Items]
Basis spread on variable rate		2.75%
European Subsidiary | Unsecured And Uncommitted Credit Line2 | Line of Credit
Debt Instrument [Line Items]
Maximum borrowing capacity | €											€ 5,000,000
European Subsidiary | Secured And Committed Credit Line | Line of Credit
Debt Instrument [Line Items]
Maximum borrowing capacity | €				€ 4,400,000
Stated interest rate		0.75%	0.75%	0.75%	0.75%
European Subsidiary | Unsecured And Uncommitted, Secured And Committed, Credit Lines | Line of Credit
Debt Instrument [Line Items]
Maximum borrowing capacity | €				€ 36,200,000
Amount outstanding | €				€ 0
Japanese Subsidiary | Unsecured And Uncommitted Overdraft Facililty1 | Overdraft Facility
Debt Instrument [Line Items]
Maximum borrowing capacity							$ 7,000,000
Amount outstanding		$ 0
Japanese Subsidiary | Unsecured And Uncommitted Overdraft Facility2 | Overdraft Facility
Debt Instrument [Line Items]
Maximum borrowing capacity | ¥					¥ 1,500,000,000			¥ 300,000,000
Japanese Subsidiary | Unsecured And Uncommitted Overdraft Facility | Overdraft Facility
Debt Instrument [Line Items]
Maximum borrowing capacity		$ 21,200,000
Stated interest rate		2.75%	2.75%	2.75%	2.75%
Japanese Subsidiary | Unsecured And Uncommitted Overdraft Facility | Overdraft Facility | Tokyo Interbank Offered Rate
Debt Instrument [Line Items]
Basis spread on variable rate		0.05%
Korean Subsidiary | Unsecured And Uncommitted Line Of Credit | Overdraft Facility | Korea Three Month CD Rate
Debt Instrument [Line Items]
Basis spread on variable rate		2.75%
Korean Subsidiary | Unsecured And Uncommitted Overdraft Facility | Overdraft Facility
Debt Instrument [Line Items]
Maximum borrowing capacity		$ 20,000,000
Amount outstanding		$ 0
China Subsidiary | Unsecured And Uncommitted Overdraft And Clean Advance Facility | Overdraft Facility | People's Bank Of China Base Rate
Debt Instrument [Line Items]
Basis spread on variable rate		10.00%
China Subsidiary | Unsecured And Uncommitted Overdraft And Clean Advance Facility | Overdraft And Clean Advance Facility
Debt Instrument [Line Items]
Maximum borrowing capacity		$ 20,000,000
Amount outstanding		0
Remaining borrowing capacity		$ 40,500,000
China Subsidiary | Unsecured And Uncommitted Overdraft And Clean Advance Facility | Overdraft And Clean Advance Facility | London Interbank Offered Rate (LIBOR)
Debt Instrument [Line Items]
Basis spread on variable rate		2.00%

Income Taxes (Details)

Income Taxes (Details) - USD ($) $ in Thousands	3 Months Ended			9 Months Ended
	Sep. 30, 2020	Jun. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019	Dec. 31, 2019
Income Tax Contingency [Line Items]
Effective Income Tax Rate Percentage Expense (Benefit)	(26.10%)		(22.00%)	(24.80%)	(18.20%)
Effective Income Tax Rate Reconciliation, Tax Credit, Foreign, Amount		$ 1,500
Deferred Income Tax Assets, Net	$ 77,055		$ 80,193	$ 77,055	$ 80,193	$ 78,849
8888 Foreign Governments [Member]
Income Tax Contingency [Line Items]
Deferred Income Tax Assets, Net	$ 7,700			$ 7,700

Product Warranty (Reconciliatio

Product Warranty (Reconciliation Of Product Warranties) (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Reconciliation of Product Warranty Accrual [Roll Forward]
Balance at beginning of period	$ 13,334	$ 13,186	$ 14,466	$ 13,186
Provision for warranty claims	525	645	1,430	3,140
Warranty claims	(493)	(440)	(2,378)	(2,899)
Other	175	(180)	23	(216)
Balance at end of period	$ 13,541	$ 13,211	$ 13,541	$ 13,211

Shareholders' Equity (Details)

Shareholders' Equity (Details) - USD ($) $ in Thousands, shares in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Equity [Abstract]
Stock Repurchased During Period, Value	$ 132,900	$ 15,769	$ 132,889	$ 116,195
Stock Repurchase Program, Authorized Amount	$ 1,100,000		$ 1,100,000
Stock Repurchase Program Number Of Shares Repurchased To Date			26.8
Stock Repurchased To Date Value			$ 1,017,800

Stock-Based Compensation (Narra

Stock-Based Compensation (Narrative) (Details)	9 Months Ended
	Sep. 30, 2020USD ($)$ / sharesshares
Employee Stock Options [Member]
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]
Stock options granted (in shares) | shares	660,071
Unrecognized costs related to share based compensation | $	$ 13,300,000
Weighted average period of recognition of unrecognized costs related to stock options, years	2 years 7 months 2 days
Equity Option [Member]
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value | $ / shares	$ 14.67
Restricted Stock Units [Member]
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value | $ / shares	$ 79.43
Unrecognized costs related to share based compensation | $	$ 21,500,000
Weighted average period of recognition of unrecognized costs related to stock options, years	2 years 4 months 2 days
Restricted stock units granted (in shares) | shares	209,972

Stock-Based Compensation (Summa

Stock-Based Compensation (Summary Of Stock-Based Compensation Expense) (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense	$ 5,090	$ 4,378	$ 12,802	$ 13,159
Employee Stock Options [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Payment Arrangement, Expense	1,775	1,509	5,234	4,600
Restricted Stock Units [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Payment Arrangement, Expense	$ 3,315	$ 2,869	$ 7,568	$ 8,559

Stock-Based Compensation (Sched

Stock-Based Compensation (Schedule Of Weighted Average Assumptions) (Details)	9 Months Ended
	Sep. 30, 2020$ / shares
Equity Option [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Weighted average grant date fair value (in dollars per share)	$ 14.67

Stock-Based Compensation (Sch_2

Stock-Based Compensation (Schedule Of Weighted Average Assumptions For Restricted Stock Units) (Details)	9 Months Ended
	Sep. 30, 2020$ / shares
Restricted Stock Units [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value	$ 79.43

Earnings Per Share (Narrative)

Earnings Per Share (Narrative) (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-dilutive securities excluded from computation of earnings per share, number of shares	1,156,073	440,993	1,282,086	378,617
Stock Repurchased During Period, Value	$ 132,900	$ 15,769	$ 132,889	$ 116,195

Earnings Per Share (Reconciliat

Earnings Per Share (Reconciliation Of Common Shares Used In Denominator For Computing Basic And Diluted EPS) (Details) - $ / shares	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Earnings Per Share [Abstract]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	1,156,073	440,993	1,282,086	378,617
Weighted average shares of common stock outstanding, used in computing basic earnings per share (in shares)	66,179,000	67,593,000	66,427,000	67,935,000
Effect of dilutive stock options and restricted stock units (in shares)	358,000	587,000	380,000	685,000
Weighted-average shares of common stock outstanding, used in computing diluted earnings per share (in shares)	66,537,000	68,180,000	66,807,000	68,620,000
Income Loss From Continuing Operations Per Basic And Diluted Share [Abstract]
Earnings (loss) per share of common stock, Basic (in dollars per share)	$ 0.95	$ 1.76	$ 0.18	$ 3.19
Earnings (loss) per share of common stock, Diluted (in dollars per share)	$ 0.94	$ 1.75	$ 0.18	$ 3.15

Accumulated Other Comprehensi_3

Accumulated Other Comprehensive Income (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Accumulated Other Comprehensive Income (Loss) [Line Items]
Accumulated other comprehensive income (loss) at beginning of period	$ (5,860)	$ (1,298)	$ (4,425)	$ (4,063)
Other comprehensive income (loss) before reclassifications	4,777	(2,074)	7,694	4,142
Amounts reclassified from other comprehensive income	(5,287)	(3,901)	(9,639)	(7,253)
Net other comprehensive income (loss) during the period	(510)	(5,975)	(1,945)	(3,111)
Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests				(16,555)
Accumulated other comprehensive income (loss) at end of period	(6,370)	(7,273)	(6,370)	(7,273)
Unrealized Gains (Losses) on Available-For-Sale Securities [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Accumulated other comprehensive income (loss) at beginning of period	(4)	(4)	(4)	(60)
Other comprehensive income (loss) before reclassifications	0	0	0	56
Amounts reclassified from other comprehensive income	0	0	0	0
Net other comprehensive income (loss) during the period	0	0	0	56
Accumulated other comprehensive income (loss) at end of period	(4)	(4)	(4)	(4)
Unrealized Holding Gains (Losses) on Derivative Transactions [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Accumulated other comprehensive income (loss) at beginning of period	16,145	11,317	9,482	11,964
Other comprehensive income (loss) before reclassifications	(6,398)	6,315	4,617	9,119
Amounts reclassified from other comprehensive income	(5,287)	(3,901)	(9,639)	(7,253)
Net other comprehensive income (loss) during the period	(11,685)	2,414	(5,022)	1,866
Accumulated other comprehensive income (loss) at end of period	4,460	13,731	4,460	13,731
Foreign Currency Translation Adjustments [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Accumulated other comprehensive income (loss) at beginning of period	(22,001)	(12,611)	(13,903)	(15,967)
Other comprehensive income (loss) before reclassifications	11,175	(8,389)	3,077	(5,033)
Amounts reclassified from other comprehensive income	0	0	0	0
Net other comprehensive income (loss) during the period	11,175	(8,389)	3,077	(5,033)
Accumulated other comprehensive income (loss) at end of period	$ (10,826)	$ (21,000)	$ (10,826)	(21,000)
AOCI Attributable to Parent [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests				$ (99)

Segment Information Concentrati

Segment Information Concentration (Details) - GeographicSegments	3 Months Ended			9 Months Ended
	Sep. 30, 2020	Mar. 31, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Concentration Risk [Line Items]
Number of Operating Segments				4
Accounts Receivable [Member]
Concentration Risk [Line Items]
Concentration Risk, Percentage		13.90%
Accounts Receivable [Member] | Customer Concentration Risk [Member]
Concentration Risk [Line Items]
Concentration Risk, Percentage				11.40%
Revenue, Product and Service Benchmark [Member]
Concentration Risk [Line Items]
Concentration Risk, Percentage	10.00%		10.00%	10.00%	10.00%

Segment Information (Schedule O

Segment Information (Schedule Of Segment Information) (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Segment Reporting Information [Line Items]
Income from operations	$ 85,643	$ 152,015	$ 13,356	$ 256,338
Interest income, net	(280)	1,399	728	7,370
Other non-operating expense	(465)	(563)	2,208	915
Income before income tax	84,898	152,851	16,292	264,623
Operating Segments [Member]
Segment Reporting Information [Line Items]
Net sales to unrelated entities	701,092	906,793	1,585,931	2,087,611
Income from operations	140,039	218,457	161,318	419,510
Corporate, Non-Segment [Member]
Segment Reporting Information [Line Items]
Unallocated corporate expenses	(54,396)	(66,442)
United States [Member] | Operating Segments [Member]
Segment Reporting Information [Line Items]
Net sales to unrelated entities	445,620	581,263	1,004,733	1,309,014
Income from operations	96,577	156,190	118,454	298,366
LAAP | Operating Segments [Member]
Segment Reporting Information [Line Items]
Net sales to unrelated entities	90,951	123,246	260,912	357,719
Income from operations	4,736	17,081	8,690	53,822
EMEA [Member] | Operating Segments [Member]
Segment Reporting Information [Line Items]
Net sales to unrelated entities	99,159	104,403	213,298	267,278
Income from operations	18,959	18,162	19,032	36,905
Canada [Member] | Operating Segments [Member]
Segment Reporting Information [Line Items]
Net sales to unrelated entities	65,362	97,881	106,988	153,600
Income from operations	$ 19,767	$ 27,024	15,142	30,417
Corporate, Non-Segment [Member]
Segment Reporting Information [Line Items]
Unallocated corporate expenses			$ (147,962)	$ (163,172)

Financial Instruments And Ris_3

Financial Instruments And Risk Management (Narrative) (Details)	Sep. 30, 2020USD ($)
Derivative [Line Items]
Deferred net gains on derivatives accumulated in other comprehensive income expected reclassification to net income in next twelve months	$ 5,100,000
Maximum
Derivative [Line Items]
Aggregate unrealized gain of derivative contracts with single counterparty	$ 2,900,000

Financial Instruments And Ris_4

Financial Instruments And Risk Management (Gross Notional Amount Of Outstanding Derivative Instruments) (Details) - Currency Forward Contracts [Member] - USD ($) $ in Thousands	Sep. 30, 2020	Dec. 31, 2019	Sep. 30, 2019
Derivative Instruments Designated As Cash Flow Hedges [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Currency forward contracts	$ 419,402	$ 471,822	$ 412,041
Derivative Instruments Not Designated As Cash Flow Hedges [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Currency forward contracts	$ 224,573	$ 214,086	$ 235,945

Financial Instruments And Ris_5

Financial Instruments And Risk Management (Balance Sheet Classification And Fair Value Of Derivative Instruments) (Details) - Currency Forward Contracts [Member] - USD ($) $ in Thousands	Sep. 30, 2020	Dec. 31, 2019	Sep. 30, 2019
Prepaid Expenses And Other Current Assets [Member] | Derivative Instruments Designated As Cash Flow Hedges [Member]
Derivatives, Fair Value [Line Items]
Fair value of derivative assets	$ 4,729	$ 11,855	$ 16,603
Prepaid Expenses And Other Current Assets [Member] | Derivative Instruments Not Designated As Cash Flow Hedges [Member]
Derivatives, Fair Value [Line Items]
Fair value of derivative assets	2,211	2,146	1,857
Other Noncurrent Assets [Member] | Derivative Instruments Designated As Cash Flow Hedges [Member]
Derivatives, Fair Value [Line Items]
Fair value of derivative assets	3,454	4,159	4,830
Accrued Liabilities [Member] | Derivative Instruments Designated As Cash Flow Hedges [Member]
Derivatives, Fair Value [Line Items]
Fair value of derivative liabilities	2,034	1,313	201
Accrued Liabilities [Member] | Derivative Instruments Not Designated As Cash Flow Hedges [Member]
Derivatives, Fair Value [Line Items]
Fair value of derivative liabilities	381	953	320
Other Long Term Liabilities [Member] | Derivative Instruments Designated As Cash Flow Hedges [Member]
Derivatives, Fair Value [Line Items]
Fair value of derivative liabilities	$ 1,186	$ 768	$ 109

Financial Instruments And Ris_6

Financial Instruments And Risk Management (Effect And Classification Of Derivative Instruments) (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Derivative Instruments Designated As Cash Flow Hedges [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Gain (loss) recognized in other comprehensive income or loss	$ (6,398)	$ 6,315	$ 4,617	$ 9,119
Cost of Sales [Member] | Derivative Instruments Designated As Cash Flow Hedges [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Gain (loss) reclassified from accumulated other comprehensive income or loss to income or loss for the effective portion	6,906	5,087	11,527	7,208
Derivative Instruments, Gain (Loss) Recognized in Income, Ineffective Portion and Amount Excluded from Effectiveness Testing, Net	0	0	0	2,380
Sales [Member] | Derivative Instruments Designated As Cash Flow Hedges [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Gain (loss) reclassified from accumulated other comprehensive income or loss to income or loss for the effective portion	80	172	123	282
Derivative Instruments, Gain (Loss) Recognized in Income, Ineffective Portion and Amount Excluded from Effectiveness Testing, Net	0	0	0	(31)
Other Non-operating Income (Expense) [Member] | Derivative Instruments Not Designated As Cash Flow Hedges [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Gain (loss) reclassified from accumulated other comprehensive income or loss to income or loss for the effective portion	60	0	1,177	0
Gain (loss) recognized in income or loss	$ (1,795)	$ 1,855	$ (465)	$ 1,281

Fair Value Measures (Assets And

Fair Value Measures (Assets And Liabilities Measured At Fair Value On A Recurring Basis) (Details) - USD ($) $ in Thousands	Sep. 30, 2020	Dec. 31, 2019	Sep. 30, 2019
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets measured at fair value	$ 84,421	$ 391,233	$ 110,598
Total liabilities measured at fair value	3,601	3,034	630
Level 1 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets measured at fair value	74,027	304,558	87,308
Total liabilities measured at fair value	0	0	0
Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets measured at fair value	10,394	86,675	23,290
Total liabilities measured at fair value	3,601	3,034	630
Level 3 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets measured at fair value	0	0	0
Total liabilities measured at fair value	0	0	0
Accrued Liabilities [Member] | Derivative Financial Instruments, Liabilities [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total liabilities measured at fair value	2,415	2,266	521
Accrued Liabilities [Member] | Derivative Financial Instruments, Liabilities [Member] | Level 1 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total liabilities measured at fair value	0	0	0
Accrued Liabilities [Member] | Derivative Financial Instruments, Liabilities [Member] | Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total liabilities measured at fair value	2,415	2,266	521
Accrued Liabilities [Member] | Derivative Financial Instruments, Liabilities [Member] | Level 3 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total liabilities measured at fair value	0	0	0
Other Long Term Liabilities [Member] | Derivative Financial Instruments, Liabilities [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total liabilities measured at fair value	1,186	768	109
Other Long Term Liabilities [Member] | Derivative Financial Instruments, Liabilities [Member] | Level 1 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total liabilities measured at fair value	0	0	0
Other Long Term Liabilities [Member] | Derivative Financial Instruments, Liabilities [Member] | Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total liabilities measured at fair value	1,186	768	109
Other Long Term Liabilities [Member] | Derivative Financial Instruments, Liabilities [Member] | Level 3 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total liabilities measured at fair value	0	0	0
Cash Equivalents [Member] | Money Market Funds [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets measured at fair value	56,337
Cash Equivalents [Member] | Money Market Funds [Member] | Level 1 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets measured at fair value	56,337
Cash Equivalents [Member] | Money Market Funds [Member] | Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets measured at fair value	0
Cash Equivalents [Member] | Money Market Funds [Member] | Level 3 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets measured at fair value	0
Cash Equivalents [Member] | US Treasury Securities [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets measured at fair value		34,928
Cash Equivalents [Member] | US Treasury Securities [Member] | Level 1 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets measured at fair value		0
Cash Equivalents [Member] | US Treasury Securities [Member] | Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets measured at fair value		34,928
Cash Equivalents [Member] | US Treasury Securities [Member] | Level 3 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets measured at fair value		0
Cash Equivalents [Member] | Commercial Paper [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets measured at fair value		33,587
Cash Equivalents [Member] | Commercial Paper [Member] | Level 1 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets measured at fair value		0
Cash Equivalents [Member] | Commercial Paper [Member] | Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets measured at fair value		33,587
Cash Equivalents [Member] | Commercial Paper [Member] | Level 3 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets measured at fair value		0
Cash and Cash Equivalents [Member] | Money Market Funds [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets measured at fair value		288,926	72,941
Cash and Cash Equivalents [Member] | Money Market Funds [Member] | Level 1 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets measured at fair value		288,926	72,941
Cash and Cash Equivalents [Member] | Money Market Funds [Member] | Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets measured at fair value		0	0
Cash and Cash Equivalents [Member] | Money Market Funds [Member] | Level 3 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets measured at fair value		0	0
Short-term Investments [Member] | Money Market Funds [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets measured at fair value	70
Short-term Investments [Member] | Money Market Funds [Member] | Level 1 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets measured at fair value	70
Short-term Investments [Member] | Money Market Funds [Member] | Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets measured at fair value	0
Short-term Investments [Member] | Money Market Funds [Member] | Level 3 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets measured at fair value	0
Short-term Investments [Member] | Mutual Fund [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets measured at fair value	1,025	1,668	1,477
Short-term Investments [Member] | Mutual Fund [Member] | Level 1 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets measured at fair value	1,025	1,668	1,477
Short-term Investments [Member] | Mutual Fund [Member] | Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets measured at fair value	0	0	0
Short-term Investments [Member] | Mutual Fund [Member] | Level 3 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets measured at fair value	0	0	0
Other Current Assets [Member] | Derivative Financial Instruments, Assets [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets measured at fair value	6,940	14,001	18,460
Other Current Assets [Member] | Derivative Financial Instruments, Assets [Member] | Level 1 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets measured at fair value	0	0	0
Other Current Assets [Member] | Derivative Financial Instruments, Assets [Member] | Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets measured at fair value	6,940	14,001	18,460
Other Current Assets [Member] | Derivative Financial Instruments, Assets [Member] | Level 3 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets measured at fair value	0	0	0
Other Noncurrent Assets [Member] | Money Market Funds [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets measured at fair value	4,621	1,792	1,528
Other Noncurrent Assets [Member] | Money Market Funds [Member] | Level 1 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets measured at fair value	4,621	1,792	1,528
Other Noncurrent Assets [Member] | Money Market Funds [Member] | Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets measured at fair value	0	0	0
Other Noncurrent Assets [Member] | Money Market Funds [Member] | Level 3 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets measured at fair value	0	0	0
Other Noncurrent Assets [Member] | Mutual Fund [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets measured at fair value	11,974	12,172	11,362
Other Noncurrent Assets [Member] | Mutual Fund [Member] | Level 1 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets measured at fair value	11,974	12,172	11,362
Other Noncurrent Assets [Member] | Mutual Fund [Member] | Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets measured at fair value	0	0	0
Other Noncurrent Assets [Member] | Mutual Fund [Member] | Level 3 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets measured at fair value	0	0	0
Other Noncurrent Assets [Member] | Derivative Financial Instruments, Assets [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets measured at fair value	3,454	4,159	4,830
Other Noncurrent Assets [Member] | Derivative Financial Instruments, Assets [Member] | Level 1 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets measured at fair value	0	0	0
Other Noncurrent Assets [Member] | Derivative Financial Instruments, Assets [Member] | Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets measured at fair value	3,454	4,159	4,830
Other Noncurrent Assets [Member] | Derivative Financial Instruments, Assets [Member] | Level 3 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets measured at fair value	$ 0	$ 0	$ 0